Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications
[Display omitted] During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid nanocarriers enable to target the therapeutic payload to deep skin layers or even to reach the blood circulation making them a promising cuttin...
Saved in:
Published in | International journal of pharmaceutics Vol. 535; no. 1-2; pp. 1 - 17 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
15.01.2018
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid nanocarriers enable to target the therapeutic payload to deep skin layers or even to reach the blood circulation making them a promising cutting-edge technology.
Lipid nanocarriers refer to a large panel of drug delivery systems. Lipid vesicles are the most conventional, known to be able to carry lipophilic and hydrophilic active agents. A variety of lipid vesicles with high flexibility and deformability could be obtained by adjusting their composition; namely ethosomes, transfersomes and penetration enhancer lipid vesicles which achieve the best results in term of skin permeation. Others are designed with the objective to perform higher encapsulation rate and higher stability, such as solid lipid nanoparticles and nanostructured lipid nanocarriers.
In this review, we attempted to give an overview of lipid based nanocarriers developed with the aim to enhance dermal and transdermal drug delivery. A special focus is put on the nanocarrier composition, behavior and interaction mechanisms with the skin. Recent applications of lipid-based nanocarriers for the management of skin diseases and other illnesses are highlighted as well. |
---|---|
AbstractList | During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid nanocarriers enable to target the therapeutic payload to deep skin layers or even to reach the blood circulation making them a promising cutting-edge technology. Lipid nanocarriers refer to a large panel of drug delivery systems. Lipid vesicles are the most conventional, known to be able to carry lipophilic and hydrophilic active agents. A variety of lipid vesicles with high flexibility and deformability could be obtained by adjusting their composition; namely ethosomes, transfersomes and penetration enhancer lipid vesicles which achieve the best results in term of skin permeation. Others are designed with the objective to perform higher encapsulation rate and higher stability, such as solid lipid nanoparticles and nanostructured lipid nanocarriers. In this review, we attempted to give an overview of lipid based nanocarriers developed with the aim to enhance dermal and transdermal drug delivery. A special focus is put on the nanocarrier composition, behavior and interaction mechanisms with the skin. Recent applications of lipid-based nanocarriers for the management of skin diseases and other illnesses are highlighted as well. [Display omitted] During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid nanocarriers enable to target the therapeutic payload to deep skin layers or even to reach the blood circulation making them a promising cutting-edge technology. Lipid nanocarriers refer to a large panel of drug delivery systems. Lipid vesicles are the most conventional, known to be able to carry lipophilic and hydrophilic active agents. A variety of lipid vesicles with high flexibility and deformability could be obtained by adjusting their composition; namely ethosomes, transfersomes and penetration enhancer lipid vesicles which achieve the best results in term of skin permeation. Others are designed with the objective to perform higher encapsulation rate and higher stability, such as solid lipid nanoparticles and nanostructured lipid nanocarriers. In this review, we attempted to give an overview of lipid based nanocarriers developed with the aim to enhance dermal and transdermal drug delivery. A special focus is put on the nanocarrier composition, behavior and interaction mechanisms with the skin. Recent applications of lipid-based nanocarriers for the management of skin diseases and other illnesses are highlighted as well. |
Author | Diab, R. Sala, M. Elaissari, A. Fessi, H. |
Author_xml | – sequence: 1 givenname: M. surname: Sala fullname: Sala, M. organization: Univ. Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 boulevard du 11 November 1918, F-69100, Villeurbanne, France – sequence: 2 givenname: R. surname: Diab fullname: Diab, R. email: roudayna.diab@univ-lorraine.fr organization: SRSMC, UMR 7565, Université de Lorraine-CNRS, F-54506 Vandœuvre-lès-Nancy, France – sequence: 3 givenname: A. surname: Elaissari fullname: Elaissari, A. email: abdelhamid.elaissari@univ-lyon1.fr organization: Univ. Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 boulevard du 11 November 1918, F-69100, Villeurbanne, France – sequence: 4 givenname: H. surname: Fessi fullname: Fessi, H. organization: Univ. Lyon, University Claude Bernard Lyon-1, CNRS, LAGEP UMR 5007, 43 boulevard du 11 November 1918, F-69100, Villeurbanne, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29111097$$D View this record in MEDLINE/PubMed https://hal.science/hal-02093089$$DView record in HAL |
BookMark | eNqFkUFv1DAQhS1URLeFnwDyEaRm8cSOE3NBVUUp0kpwgLPl2g7rJbGDJ7vS_nu8ZOmV01jj781o3rsiFzFFT8hrYGtgIN_v1mE3bU0e1zWDtvTWTMhnZAVdyysuWnlBVoy3XdVAyy_JFeKOMSZr4C_IZa0AgKl2RQ6bMAVHo4nJmpyDz0gNUvwVInV5_5M6P4SDz0eKR5z9iB_ot5wmn-fg8YaO3m5NDDgiTf2iCnH22dg5pFhGRVcYF6wZqJmmoTz-frwkz3szoH91rtfkx_2n73cP1ebr5y93t5vKcqXmSrZ9wwW3Xd_0wgroavdolRVGQcsYdMqYTihohGSKSytd7Xi515lSate3_Jq8W-ZuzaCnHEaTjzqZoB9uN_rUY3VRsk4doLBvF3bK6ffe46zHgNYPg4k-7VGDkiCF4E1X0GZBbU6I2fdPs4HpUzx6p8_x6FM8p3aJp-jenFfsH4stT6p_eRTg4wL4YsqhpKHRBh9tsTB7O2uXwn9W_AHZBqYp |
CitedBy_id | crossref_primary_10_1016_j_colsurfb_2021_111748 crossref_primary_10_1080_02652048_2024_2326085 crossref_primary_10_1038_s41443_020_0235_7 crossref_primary_10_1016_j_jddst_2019_04_039 crossref_primary_10_1016_j_ejps_2018_10_005 crossref_primary_10_4155_tde_2023_0024 crossref_primary_10_2174_1381612827666210810091745 crossref_primary_10_51585_gjvr_2022_4_0043 crossref_primary_10_1016_j_onano_2023_100123 crossref_primary_10_1080_09205063_2022_2054399 crossref_primary_10_3390_pharmaceutics12111010 crossref_primary_10_1016_j_ijpharm_2024_123948 crossref_primary_10_1080_1040841X_2020_1843399 crossref_primary_10_1007_s40204_021_00154_7 crossref_primary_10_1016_j_saa_2022_121152 crossref_primary_10_2174_1567201816666190118125427 crossref_primary_10_1021_acsomega_2c05976 crossref_primary_10_3390_coatings10040304 crossref_primary_10_1080_17425247_2021_2011857 crossref_primary_10_3390_cosmetics10020054 crossref_primary_10_3390_pharmaceutics14040831 crossref_primary_10_1080_17425247_2020_1767583 crossref_primary_10_1208_s12249_023_02504_z crossref_primary_10_1002_smll_202002515 crossref_primary_10_1016_j_jddst_2022_103595 crossref_primary_10_1007_s12325_023_02541_x crossref_primary_10_1016_j_jddst_2020_101616 crossref_primary_10_1016_j_molliq_2020_113771 crossref_primary_10_3390_nano12040636 crossref_primary_10_1016_j_ijpharm_2022_122290 crossref_primary_10_3390_pharmaceutics13071004 crossref_primary_10_1016_j_ijpharm_2019_04_001 crossref_primary_10_1016_j_colsurfa_2021_126340 crossref_primary_10_1016_j_ijpharm_2020_119336 crossref_primary_10_1007_s11356_020_10100_y crossref_primary_10_1016_j_jconrel_2023_03_049 crossref_primary_10_1208_s12249_023_02648_y crossref_primary_10_1111_ics_12607 crossref_primary_10_3390_molecules28031449 crossref_primary_10_3390_pharmaceutics16040449 crossref_primary_10_3389_fbioe_2021_597958 crossref_primary_10_3390_ijms19071865 crossref_primary_10_3390_pharmaceutics12111127 crossref_primary_10_2174_0929867327666200831125656 crossref_primary_10_1016_j_jconrel_2022_07_014 crossref_primary_10_2147_IJN_S330716 crossref_primary_10_2147_IJN_S450181 crossref_primary_10_1016_j_addr_2020_02_005 crossref_primary_10_1080_17425247_2020_1758665 crossref_primary_10_1039_D2TB00614F crossref_primary_10_1016_j_jddst_2019_101232 crossref_primary_10_1016_j_jphotobiol_2023_112650 crossref_primary_10_1016_j_ijpharm_2019_118582 crossref_primary_10_3390_molecules26195989 crossref_primary_10_1002_app_46914 crossref_primary_10_1016_j_ijpharm_2023_123668 crossref_primary_10_1093_jaoacint_qsad100 crossref_primary_10_1111_jocd_15158 crossref_primary_10_1111_exd_14966 crossref_primary_10_1002_mabi_202100103 crossref_primary_10_3389_fbioe_2021_646554 crossref_primary_10_1016_j_ijpharm_2021_121440 crossref_primary_10_1038_s41598_021_04708_4 crossref_primary_10_1080_17460441_2020_1750591 crossref_primary_10_3390_ijms20225659 crossref_primary_10_1016_j_colsurfb_2019_02_007 crossref_primary_10_1142_S0219455423501432 crossref_primary_10_3390_pharmaceutics12060587 crossref_primary_10_1021_acs_molpharmaceut_0c00041 crossref_primary_10_2174_1874467213999201109220714 crossref_primary_10_1016_j_jddst_2022_103780 crossref_primary_10_3390_molecules26226786 crossref_primary_10_3389_fchem_2023_1257915 crossref_primary_10_1208_s12249_018_1262_2 crossref_primary_10_3390_app11114915 crossref_primary_10_3390_polym16101362 crossref_primary_10_1016_j_molliq_2021_117145 crossref_primary_10_3390_pharmaceutics11120644 crossref_primary_10_2174_1567201817666200826093102 crossref_primary_10_3390_membranes13030343 crossref_primary_10_1016_j_ijpharm_2020_119126 crossref_primary_10_1002_wnan_1633 crossref_primary_10_1016_j_ejps_2017_11_023 crossref_primary_10_2217_nnm_2020_0116 crossref_primary_10_1002_wnan_1636 crossref_primary_10_1080_02652048_2021_1887383 crossref_primary_10_1016_j_drudis_2020_09_023 crossref_primary_10_1016_j_ejphar_2021_174254 crossref_primary_10_1007_s00289_021_03658_1 crossref_primary_10_3390_bios8020040 crossref_primary_10_2174_1568009618666180628160211 crossref_primary_10_1016_j_chemphyslip_2023_105290 crossref_primary_10_1016_j_colsurfa_2022_130914 crossref_primary_10_1016_j_mtchem_2022_101204 crossref_primary_10_3390_ijms222312754 crossref_primary_10_1016_j_ejpb_2022_05_012 crossref_primary_10_2174_0929867330666221115103513 crossref_primary_10_1208_s12249_020_01821_x crossref_primary_10_2174_1381612827666210820095330 crossref_primary_10_3390_pharmaceutics13111968 crossref_primary_10_1016_j_jconrel_2019_03_003 crossref_primary_10_1016_j_jddst_2019_01_028 crossref_primary_10_2174_1389450121666201106145022 crossref_primary_10_1016_j_bbcan_2022_188703 crossref_primary_10_1016_j_ijpharm_2020_120122 crossref_primary_10_1016_j_colsurfa_2022_128609 crossref_primary_10_1016_j_cocis_2023_101701 crossref_primary_10_20402_ajbc_2022_0087 crossref_primary_10_1007_s13346_020_00723_6 crossref_primary_10_1016_j_cis_2020_102121 crossref_primary_10_1016_j_compbiomed_2021_104475 crossref_primary_10_1089_jop_2023_0161 crossref_primary_10_3390_gels8020129 crossref_primary_10_1016_j_jddst_2022_103566 crossref_primary_10_1080_10837450_2022_2103147 crossref_primary_10_1016_j_jddst_2020_102313 crossref_primary_10_2174_1567201819666220524154448 crossref_primary_10_1016_j_carbpol_2019_115143 crossref_primary_10_1208_s12249_019_1457_1 crossref_primary_10_1016_j_ejpb_2019_09_016 crossref_primary_10_1016_j_ijpharm_2023_122897 crossref_primary_10_1021_acsabm_0c01143 crossref_primary_10_3390_pharmaceutics15020656 crossref_primary_10_1002_adtp_201900116 crossref_primary_10_1016_j_ejpb_2020_09_001 crossref_primary_10_1016_j_ejpb_2021_04_026 crossref_primary_10_1016_j_ijpharm_2020_119398 crossref_primary_10_1016_j_microb_2024_100051 crossref_primary_10_3390_ijms19030705 crossref_primary_10_1007_s13346_022_01134_5 crossref_primary_10_1016_j_biopha_2022_112633 crossref_primary_10_3390_pharmaceutics13091386 crossref_primary_10_7841_ksbbj_2023_38_4_203 crossref_primary_10_1016_j_cis_2020_102261 crossref_primary_10_2174_1872211313666191024112137 crossref_primary_10_1142_S1793292021501289 crossref_primary_10_1002_smll_202301670 crossref_primary_10_1016_j_addr_2024_115197 crossref_primary_10_1021_acs_biomac_1c01100 crossref_primary_10_1039_D0BM01717E crossref_primary_10_1021_acs_molpharmaceut_1c00970 crossref_primary_10_3390_pharmaceutics12121224 crossref_primary_10_1016_j_ajps_2018_05_007 crossref_primary_10_1016_j_apmt_2022_101438 crossref_primary_10_2174_1381612829666230803111120 crossref_primary_10_1016_j_jconrel_2021_08_039 crossref_primary_10_1007_s10853_022_07679_7 crossref_primary_10_1016_j_jddst_2022_103195 crossref_primary_10_1007_s12247_022_09635_z crossref_primary_10_1016_j_ejps_2021_106029 crossref_primary_10_1016_j_envres_2023_116467 crossref_primary_10_3390_pharmaceutics16020222 crossref_primary_10_1016_j_colsurfb_2019_05_057 crossref_primary_10_1002_ejlt_202000389 crossref_primary_10_1021_acsami_8b21967 crossref_primary_10_3389_fbioe_2023_1177151 crossref_primary_10_1016_j_ijpharm_2021_120653 crossref_primary_10_1111_dth_13905 crossref_primary_10_1021_acsomega_2c03039 crossref_primary_10_1016_j_jddst_2022_103878 crossref_primary_10_3390_pharmaceutics11110588 crossref_primary_10_3390_molecules27185887 crossref_primary_10_1016_j_procbio_2024_07_002 crossref_primary_10_1002_ppsc_202300147 crossref_primary_10_1016_j_indcrop_2020_112658 crossref_primary_10_1016_j_ijbiomac_2024_132745 crossref_primary_10_1016_j_ijpharm_2021_120762 crossref_primary_10_2147_IJN_S263516 crossref_primary_10_3390_ma13030570 crossref_primary_10_1016_j_pscia_2023_100031 crossref_primary_10_1016_j_ijpharm_2019_118623 crossref_primary_10_1615_CritRevTherDrugCarrierSyst_v41_i5_20 crossref_primary_10_1016_j_jddst_2021_102397 crossref_primary_10_2147_DDDT_S264648 crossref_primary_10_1016_j_jddst_2022_103881 crossref_primary_10_3390_antiox10071034 crossref_primary_10_1016_j_ejps_2020_105434 crossref_primary_10_1208_s12249_020_01831_9 crossref_primary_10_1016_j_ijpharm_2021_121290 crossref_primary_10_1016_j_jddst_2023_105174 crossref_primary_10_35516_jjps_v17i1_1313 crossref_primary_10_1016_j_molliq_2021_118430 crossref_primary_10_2174_138161282636200910103611 crossref_primary_10_1007_s11095_021_03053_5 crossref_primary_10_1080_01932691_2018_1467779 crossref_primary_10_3390_ijms22158319 crossref_primary_10_3390_pharmaceutics15082165 crossref_primary_10_3390_colloids5010018 crossref_primary_10_1007_s10311_018_00841_1 crossref_primary_10_3390_ph14111083 crossref_primary_10_3390_nano13101688 crossref_primary_10_3390_vaccines12040409 crossref_primary_10_1016_j_jconrel_2022_01_019 crossref_primary_10_2174_1381612826666200614175236 crossref_primary_10_1080_10717544_2020_1754527 crossref_primary_10_1080_10717544_2022_2053761 crossref_primary_10_1248_cpb_c18_00384 crossref_primary_10_1016_j_ijpharm_2021_121273 crossref_primary_10_3390_ph16101492 crossref_primary_10_1016_j_actbio_2019_12_025 crossref_primary_10_1016_j_jddst_2021_102331 crossref_primary_10_1080_02652048_2023_2183276 crossref_primary_10_1016_j_semcancer_2019_11_012 crossref_primary_10_2174_1389201024666221223095315 crossref_primary_10_1002_pi_5674 crossref_primary_10_1055_a_1974_9078 crossref_primary_10_1080_02652048_2022_2131920 crossref_primary_10_1080_09205063_2022_2103625 crossref_primary_10_1039_D0RA09561C crossref_primary_10_1208_s12249_022_02328_3 crossref_primary_10_1016_j_jcrysgro_2023_127245 crossref_primary_10_1016_j_jddst_2019_05_048 crossref_primary_10_1039_D1TB00557J crossref_primary_10_1080_17425247_2019_1645119 crossref_primary_10_1016_j_pacs_2023_100530 crossref_primary_10_2174_1381612825666190206195304 crossref_primary_10_1016_j_ejps_2019_01_013 crossref_primary_10_1016_j_ijbiomac_2022_09_134 crossref_primary_10_1016_j_jddst_2021_102688 crossref_primary_10_1080_17425247_2021_1951218 crossref_primary_10_3390_pharmaceutics12010025 crossref_primary_10_1007_s40005_020_00501_z crossref_primary_10_3390_pharmaceutics13030404 crossref_primary_10_1016_j_ijpharm_2021_120289 crossref_primary_10_3390_life14050599 crossref_primary_10_1021_acsnano_1c05321 crossref_primary_10_1021_acsnano_1c09367 crossref_primary_10_1080_10837450_2021_2004606 crossref_primary_10_3390_medsci7090091 crossref_primary_10_1016_j_nano_2022_102561 crossref_primary_10_1021_acs_nanolett_2c01332 crossref_primary_10_1016_j_ejps_2020_105638 crossref_primary_10_1111_wrr_12811 crossref_primary_10_1016_j_trac_2023_117275 crossref_primary_10_2174_1872211313666191030155837 crossref_primary_10_1007_s43440_023_00510_3 crossref_primary_10_1016_j_ncrna_2023_05_008 crossref_primary_10_17221_102_2020_PPS crossref_primary_10_1016_j_saa_2019_117392 crossref_primary_10_1016_j_jfutfo_2023_06_003 crossref_primary_10_1016_j_yrtph_2020_104836 crossref_primary_10_1002_ptr_7460 crossref_primary_10_1016_j_ijpharm_2022_121789 crossref_primary_10_1016_j_ejpb_2024_114233 crossref_primary_10_1016_j_ejpb_2019_02_012 crossref_primary_10_12677_MS_2020_104025 crossref_primary_10_1007_s13346_021_01021_5 crossref_primary_10_1016_j_ijpharm_2019_118935 crossref_primary_10_1016_j_ejpb_2018_11_009 crossref_primary_10_1080_1539445X_2021_2019056 crossref_primary_10_1016_j_colsurfa_2020_125396 crossref_primary_10_2147_CCID_S313429 crossref_primary_10_3390_molecules27154865 |
Cites_doi | 10.1016/j.ijpharm.2013.08.034 10.3109/08982104.2013.819888 10.1016/j.ejpb.2009.07.011 10.1007/BF00315408 10.1016/j.ijpharm.2008.10.003 10.3109/02652049009040470 10.1016/j.ijpharm.2013.08.019 10.1016/j.jconrel.2007.05.006 10.1016/j.ijpharm.2013.07.060 10.1016/j.ejpb.2012.02.008 10.1111/j.1365-2133.1995.tb08713.x 10.1016/j.ijpharm.2010.02.004 10.3390/ijms17091440 10.1016/S0378-5173(00)00493-2 10.1016/S0005-2760(96)00126-9 10.4155/tde.10.16 10.1016/S0168-3659(01)00391-1 10.2147/IJN.S60674 10.3109/02652040903367327 10.1093/toxsci/kfj014 10.1038/sj.jid.5700733 10.1159/000440984 10.1016/j.ejpb.2013.11.004 10.1016/j.ijpharm.2005.08.016 10.1159/000085861 10.1080/03602530701690366 10.1016/S0378-5173(99)00095-2 10.1016/j.jconrel.2007.08.005 10.1016/j.ejpb.2008.08.019 10.1016/j.ijpharm.2004.02.024 10.1016/S0302-4598(96)05128-8 10.1016/j.jconrel.2012.09.017 10.1371/journal.pone.0092978 10.15537/smj.2016.12.17059 10.3109/21691401.2014.883401 10.1016/j.ejpb.2011.01.011 10.1016/j.colsurfa.2009.04.006 10.1081/DDC-120025458 10.1016/j.ijpharm.2009.06.040 10.1016/j.ijpharm.2011.03.049 10.1016/0168-3659(95)00127-1 10.1073/pnas.1618300114 10.1118/1.595079 10.2174/1874126600701010036 10.1016/S0168-3659(03)00202-5 10.1111/j.1467-2494.2005.00264.x 10.1016/j.ijpharm.2010.06.034 10.1016/j.jconrel.2014.05.054 10.1016/j.ijpharm.2012.12.041 10.1111/j.2042-7158.1987.tb03407.x 10.1016/j.jconrel.2008.02.011 10.1016/j.ejpb.2012.05.011 10.1016/j.jconrel.2004.11.020 10.1016/j.ijpharm.2009.06.027 10.1016/j.ijpharm.2012.12.003 10.1016/0005-2736(95)00100-H 10.1080/10717540500176910 10.4314/tjpr.v8i2.44527 10.1016/j.ejpb.2010.05.001 10.1097/01.all.0000011028.08297.b3 10.1016/j.ijpharm.2011.03.068 10.1016/j.ejpb.2008.11.001 10.1016/j.elstat.2012.11.014 10.3109/00498258709043943 10.1016/j.ejpb.2010.12.010 10.1016/S0378-5173(98)00085-4 10.1016/j.cocis.2012.02.001 10.15171/apb.2016.06 10.1016/j.jconrel.2004.02.028 10.1016/0378-5173(94)90178-3 10.1016/S0169-409X(01)00157-0 10.1016/j.jconrel.2003.10.014 10.3109/03639045.2012.686509 10.1016/j.ijpharm.2013.02.040 10.1007/s11095-013-1229-7 10.1016/j.jconrel.2007.12.013 10.1016/j.ejpb.2009.08.001 10.1016/S0168-3659(99)00222-9 10.1016/j.ejpb.2011.05.012 10.1016/0168-3659(96)01349-1 10.1111/j.1365-2133.1988.tb03262.x 10.1016/j.ijpharm.2005.02.021 10.1016/j.ejpb.2010.10.015 10.1080/10934529.2015.975042 10.1016/S0005-2736(02)00401-7 10.1016/j.ijpharm.2013.06.052 10.3109/09687688.2010.522203 10.1039/c3ra23411h 10.1016/j.ejps.2008.05.002 10.1038/sj.jid.5700226 10.1016/j.ijpharm.2005.11.045 10.1155/2013/616810 10.3923/jpahs.2012.21.39 10.3109/03639045.2011.650648 10.1016/S0928-0987(98)00041-4 10.3109/10611869609046267 10.1016/S0378-5173(99)00361-0 10.1016/j.drudis.2012.06.013 10.1016/j.ijpharm.2006.12.005 10.1016/j.jphotobiol.2016.09.032 10.1016/0005-2736(92)90154-E 10.1016/j.jconrel.2005.09.045 10.1016/S0142-9612(00)00063-6 10.1016/j.ijpharm.2004.02.032 10.1111/exd.12051 10.1016/S0378-5173(01)00824-9 10.1016/j.ejpb.2007.08.002 10.1142/S1793545815300049 10.3390/pharmaceutics3030497 10.1023/A:1016236932339 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | NPM AAYXX CITATION 7X8 1XC |
DOI | 10.1016/j.ijpharm.2017.10.046 |
DatabaseName | PubMed CrossRef MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-3476 |
EndPage | 17 |
ExternalDocumentID | oai_HAL_hal_02093089v1 10_1016_j_ijpharm_2017_10_046 29111097 S0378517317310268 |
Genre | Journal Article Review |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSP SSZ T5K TEORI ~02 ~G- AAQFI AAXKI AKRWK NPM .GJ 29J 3O- 53G 5VS AAQXK AAYXX ABXDB ADMUD AFJKZ ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HMT HVGLF HZ~ R2- SEW SPT WUQ ZXP 7X8 1XC |
ID | FETCH-LOGICAL-c399t-67f5343c8f5f4c4182dbc9c4a91700189aa84915460936c6d2d3517dad352df73 |
IEDL.DBID | AIKHN |
ISSN | 0378-5173 |
IngestDate | Fri Sep 06 12:35:59 EDT 2024 Fri Aug 16 08:44:03 EDT 2024 Thu Sep 26 16:34:39 EDT 2024 Sat Sep 28 08:48:54 EDT 2024 Fri Feb 23 02:29:55 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-2 |
Keywords | Nanoparticles Nanocarrier Disease Permeation Transfersomes Dermal Delivery Liposomes Transdermal Ethosomes |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c399t-67f5343c8f5f4c4182dbc9c4a91700189aa84915460936c6d2d3517dad352df73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0001-9223-0353 0000-0002-2151-9894 |
PMID | 29111097 |
PQID | 1961644358 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | hal_primary_oai_HAL_hal_02093089v1 proquest_miscellaneous_1961644358 crossref_primary_10_1016_j_ijpharm_2017_10_046 pubmed_primary_29111097 elsevier_sciencedirect_doi_10_1016_j_ijpharm_2017_10_046 |
PublicationCentury | 2000 |
PublicationDate | 2018-01-15 |
PublicationDateYYYYMMDD | 2018-01-15 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | International journal of pharmaceutics |
PublicationTitleAlternate | Int J Pharm |
PublicationYear | 2018 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Guy, Hadgraft, Bucks (bib0235) 1987; 17 Morrow, McCarron, Woolfson, Donnelly (bib0415) 2007; 1 Zellmer, Pfeil, Lasch (bib0595) 1995; 1237 Zhao, Lu, Zhang, Xiao, Zhao, Tian, Xu, Feng, Xu (bib0610) 2013; 454 Cronin, Dearden, Moss, Murray-Dickson (bib0100) 1999; 7 Desai, Patlolla, Singh (bib0120) 2010; 27 Bhalaria, Naik, Misra (bib0035) 2009; 47 Lademann, Richter, Schanzer, Knorr, Meinke, Sterry, Patzelt (bib0335) 2011; 77 Kato, Ishibashi, Miyake (bib0285) 1987; 39 Dayan, Touitou (bib0115) 2000; 21 Chen, Liu, Wan, Cheng, Gu, Zhou, Chen, Zhao, Tang, Yang (bib0085) 2013; 39 Castangia, Manca, Matricardi, Sinico, Lampis, Fernàndez-Busquets, Fadda, Manconi (bib0065) 2013; 456 Jensen, Petersson, Nielsen (bib0265) 2011; 79 Manconi, Mura, Sinico, Fadda, Vila, Molina (bib0390) 2009; 342 Keith, Snipes (bib0295) 1982 Lombardi Borgia, Regehly, Sivaramakrishnan, Mehnert, Korting, Danker, Röder, Kramer, Schäfer-Korting (bib0375) 2005; 110 Gillet, Compère, Lecomte, Hubert, Ducat, Evrard, Piel (bib0210) 2011; 411 El Maghraby, Campbell, Finnin (bib0150) 2005; 305 Mardhiah Adib, Ghanbarzadeh, Kouhsoltani, Yari Khosroshahi, Hamishehkar (bib0405) 2016; 6 El Maghraby, Awad, Holayel, Mortada (bib0160) 2010; 397 Teeranachaideekul, Boonme, Souto, Müller, Junyaprasert (bib0540) 2008; 128 Lademann, Knorr, Richter, Jung, Meinke, Rühl, Alexiev, Calderon, Patzelt (bib0340) 2015; 08 Gillet, Lecomte, Hubert, Ducat, Evrard, Piel (bib0215) 2011; 79 Ghanbarzadeh, Arami (bib0200) 2013; 2013 Bolzinger, Briançon, Pelletier, Chevalier (bib0045) 2012; 17 Vogt, Combadiere, Hadam, Stieler, Lademann, Schaefer, Autran, Sterry, Blume-Peytavi (bib0565) 2006; 126 Cevc, Blume (bib0070) 1992; 1104 Hood, Kendall, Junqueira, Vreeland, Quezado, Finkel, DeVoe (bib0255) 2014; 9 Ainbinder, Touitou (bib0005) 2005; 12 Oesch, Fabian, Oesch-Bartlomowicz, Werner, Landsiedel (bib0435) 2007; 39 Zhai, Zhai (bib0605) 2014; 193 Trauer, Richter, Kuntsche, Büttemeyer, Liebsch, Linscheid, Fahr, Schäfer-Korting, Lademann, Patzelt (bib0555) 2014; 86 Dragicevic-Curic, Scheglmann, Albrecht, Fahr (bib0125) 2008; 127 Manconi, Sinico, Caddeo, Vila, Valenti, Fadda (bib0400) 2011; 412 Lei Zhang (bib0360) 1997; 42 Manconi, Caddeo, Sinico, Valenti, Mostallino, Biggio, Fadda (bib0395) 2011; 78 Riviere, Papich (bib0500) 2001; 50 Phatak, Chaudhari (bib0460) 2013; 7 Melnik, Hollmann, Plewig (bib0410) 1988; 119 Almandil (bib0015) 2016; 37 Gillet, Grammenos, Compère, Evrard, Piel (bib0205) 2009; 380 Elsayed, Abdallah, Naggar, Khalafallah (bib0165) 2007; 332 Esposito, Menegatti, Cortesi (bib0170) 2004; 55 Laouini, Charcosset, Fessi, Holdich, Vladisavljević (bib0350) 2013; 3 Sinico, Manconi, Peppi, Lai, Valenti, Fadda (bib0520) 2005; 103 Fang, Huang, Wu, Tsai (bib0175) 2009; 73 Szura, Ozimek, Przybyło, Karłowicz-Bodalska, Jaźwińska-Tarnawska, Wiela-Hojeńska, Han (bib0535) 2014; 71 Subongkot, Wonglertnirant, Songprakhon, Rojanarata, Opanasopit, Ngawhirunpat (bib0530) 2013; 441 Potts, Guy (bib0475) 1995; 12 Chessa, Caddeo, Valenti, Manconi, Sinico, Fadda (bib0090) 2011; 3 Godin, Touitou (bib0220) 2004; 94 Regnier, De Morre, Jadoul, Préat (bib0495) 1999; 184 Choi, Maibach (bib0095) 2005; 27 Siafaka, Üstündağ Okur, Karavas, Bikiaris (bib0510) 2016; 17 Foldvari, Gesztes, Mezei (bib0180) 1990; 7 Yoshida, Yokota, Foglio, Rodrigues, Pinho (bib0590) 2010; 27 Hadgraft (bib0240) 1999; 184 Paudel, Milewski, Swadley, Brogden, Ghosh, Stinchcomb (bib0455) 2010; 1 Yokomizo, Sagitani (bib0580) 1996; 38 du Plessis, Ramachandran, Weiner, Müller (bib0615) 1994; 103 Cevc, Schätzlein, Richardsen (bib0075) 2002; 1564 López-Pinto, González-Rodríguez, Rabasco (bib0330) 2005; 298 Obeidat, Schwabe, Müller, Keck (bib0430) 2010; 76 Lévy, Okada, Béziat, Moriya, Liu, Chai, Migaud, Hauck, Al Ali, Cyrus, Vatte, Patiroglu, Unal, Ferneiny, Hyakuna, Nepesov, Oleastro, Ikinciogullari, Dogu, Asano, Ohara, Yun, Della Mina, Bronnimann, Itan, Gothe, Bustamante, Boisson-Dupuis, Tahuil, Aytekin, Salhi, Al Muhsen, Kobayashi, Toubiana, Abel, Li, Camcioglu, Celmeli, Klein, AlKhater, Casanova, Puel (bib0325) 2016; 113 Manconi, Sinico, Valenti, Lai, Fadda (bib0385) 2006; 311 Lane (bib0345) 2013; 447 El Maghraby, Williams, Barry (bib0140) 2000; 204 Yatvin, Lelkes (bib0575) 1982; 9 Kang, Yap, Lim, Chen, Ho, Chan, Wong, Chan (bib0280) 2007; 120 Manca, Zaru, Manconi, Lai, Valenti, Sinico, Fadda (bib0380) 2013; 455 Verma, Fahr (bib0560) 2004; 97 Williams (bib0570) 2003 Darwhekar, Jain, Choudhary (bib0110) 2012; 7 Küchler, Herrmann, Panek-Minkin, Blaschke, Zoschke, Kramer, Bittl, Schäfer-Korting (bib0275) 2010; 390 Geusens, Van Gele, Braat, De Smedt, Stuart, Prow, Sanchez, Roberts, Sanders, Lambert (bib0195) 2010; 62 Guo, Ping, Sun, Jiao (bib0230) 2000; 194 Korting, Zienicke, Schäfer-Korting, Braun-Falco (bib0310) 1990; 39 Cui, Liang, Ma, Guo, Liu, Jiang (bib0105) 2013; 71 Rai, Gupta, Jain, Jain (bib0480) 2008; 62 Teyssou, R., Koeck, J.-L., Buisson, Y., 2008. La flore cutanée./data/revues/03389898/19970291/9780114X/. Alexander, Dwivedi, Giri, Saraf, Saraf, Tripathi (bib0010) 2012; 164 Pirvu, Hlevca, Ortan, Prisada (bib0465) 2010; 58 Baron, Merk (bib0025) 2001; 1 Lee, Shen, Lai, Hu, Fang (bib0355) 2001; 75 Souto, Wissing, Barbosa, Müller (bib0525) 2004; 278 Knorr, Lademann, Patzelt, Sterry, Blume-Peytavi, Vogt (bib0305) 2009; 71 Fresta, Puglisi (bib0185) 1996; 4 Sherry, Charcosset, Fessi, Greige-Gerges (bib0505) 2013; 23 Kumar, Pathak, Bali (bib0320) 2012; 17 Zellmer, Pfeil, Lasch (bib0600) 1995; 1237 Frušić-Zlotkin, Soroka, Tivony, Larush, Verkhovsky, Brégégère, Neuman, Magdassi, Milner (bib0190) 2012; 21 Honeywell-Nguyen, Wouter Groenink, de Graaff, Bouwstra (bib0250) 2003; 90 Korting, Stolz, Schmid, Maierhofer (bib0315) 1995; 132 Baroli, Ennas, Loffredo, Isola, Pinna, López-Quintela (bib0020) 2007; 127 Duangjit, Pamornpathomkul, Opanasopit, Rojanarata, Obata, Takayama, Ngawhirunpat (bib0130) 2014; 9 Pathan, Setty (bib0450) 2009; 8 Gu, Gao, Hou, Ding, Zhang, Gao, Ding (bib0225) 2009; 73 Kawadkar, Pathak, Kishore, Chauhan (bib0290) 2013; 39 Randhawa, Gondal, Al-Zahrani, Rashid, Ali (bib0485) 2015; 50 Kirjavainen, Urtti, Jääskeläinen, Suhonen, Paronen, Valjakka-Koskela, Kiesvaara, Mönkkönen (bib0300) 1996; 1304 Paolino, Celia, Trapasso, Cilurzo, Fresta (bib0440) 2012; 81 Touitou, Dayan, Bergelson, Godin, Eliaz (bib0550) 2000; 65 van der Merwe, Brooks, Gehring, Baynes, Monteiro-Riviere, Riviere (bib0620) 2006; 89 Loftsson, Petersen, Le Goffic, Olafsson (bib0370) 1997; 52 Hayden, Cross, Anderson, Saunders, Roberts (bib0245) 2005; 18 Singh, Pradhan, Nag, Singh (bib0515) 2015; 43 Yokomizo, Sagitani (bib0585) 1996; 42 Küchler, Radowski, Blaschke, Dathe, Plendl, Haag, Schäfer-Korting, Kramer (bib0270) 2009; 71 Jain, Jain, Umamaheshwari, Jain (bib0260) 2003; 29 El Maghraby, Williams, Barry (bib0145) 2004; 276 Cal, Centkowska (bib0060) 2008; 68 Mura, Manconi, Sinico, Valenti, Fadda (bib0420) 2009; 380 Bhoyar, Giri, Tripathi, Alexander (bib0040) 2012; 2 Nawaz, Abbasi, Hisaindee (bib0425) 2016; 164 Chathoth, Al-Mueilo, Cyrus, Vatte, Al-Nafaie, Al-Ali, Keating, Al-Muhanna, Al Ali (bib0080) 2015; 6 El Maghraby, Barry, Williams (bib0155) 2008; 34 Bouwstra, Hofland, Spies, Gooris, Junginger (bib0050) 1992 Pardeike, Hommoss, Müller (bib0445) 2009; 366 Raza, Singh, Lohan, Sharma, Negi, Yachha, Katare (bib0490) 2013; 456 Caddeo, Sales, Valenti, Saurí, Fadda, Manconi (bib0055) 2013; 443 Porter, Williams, Trevaskis (bib0470) 2013; 30 Dubey, Mishra, Dutta, Nahar, Saraf, Jain (bib0135) 2007; 123 Li, Fan, Fan, Li, Wang, Li, Liu (bib0365) 2012; 82 Betz, Imboden, Imanidis (bib0030) 2001; 229 Küchler (10.1016/j.ijpharm.2017.10.046_bib0275) 2010; 390 Ghanbarzadeh (10.1016/j.ijpharm.2017.10.046_bib0200) 2013; 2013 Li (10.1016/j.ijpharm.2017.10.046_bib0365) 2012; 82 Manconi (10.1016/j.ijpharm.2017.10.046_bib0395) 2011; 78 Dragicevic-Curic (10.1016/j.ijpharm.2017.10.046_bib0125) 2008; 127 Ainbinder (10.1016/j.ijpharm.2017.10.046_bib0005) 2005; 12 Darwhekar (10.1016/j.ijpharm.2017.10.046_bib0110) 2012; 7 Cui (10.1016/j.ijpharm.2017.10.046_bib0105) 2013; 71 Godin (10.1016/j.ijpharm.2017.10.046_bib0220) 2004; 94 Pardeike (10.1016/j.ijpharm.2017.10.046_bib0445) 2009; 366 Singh (10.1016/j.ijpharm.2017.10.046_bib0515) 2015; 43 Obeidat (10.1016/j.ijpharm.2017.10.046_bib0430) 2010; 76 10.1016/j.ijpharm.2017.10.046_bib0545 Rai (10.1016/j.ijpharm.2017.10.046_bib0480) 2008; 62 Cevc (10.1016/j.ijpharm.2017.10.046_bib0070) 1992; 1104 Korting (10.1016/j.ijpharm.2017.10.046_bib0315) 1995; 132 Fresta (10.1016/j.ijpharm.2017.10.046_bib0185) 1996; 4 Pirvu (10.1016/j.ijpharm.2017.10.046_bib0465) 2010; 58 Caddeo (10.1016/j.ijpharm.2017.10.046_bib0055) 2013; 443 Choi (10.1016/j.ijpharm.2017.10.046_bib0095) 2005; 27 Manconi (10.1016/j.ijpharm.2017.10.046_bib0385) 2006; 311 Cevc (10.1016/j.ijpharm.2017.10.046_bib0075) 2002; 1564 Desai (10.1016/j.ijpharm.2017.10.046_bib0120) 2010; 27 Manconi (10.1016/j.ijpharm.2017.10.046_bib0400) 2011; 412 Korting (10.1016/j.ijpharm.2017.10.046_bib0310) 1990; 39 Knorr (10.1016/j.ijpharm.2017.10.046_bib0305) 2009; 71 Frušić-Zlotkin (10.1016/j.ijpharm.2017.10.046_bib0190) 2012; 21 Bouwstra (10.1016/j.ijpharm.2017.10.046_bib0050) 1992 Honeywell-Nguyen (10.1016/j.ijpharm.2017.10.046_bib0250) 2003; 90 Hayden (10.1016/j.ijpharm.2017.10.046_bib0245) 2005; 18 Chessa (10.1016/j.ijpharm.2017.10.046_bib0090) 2011; 3 Oesch (10.1016/j.ijpharm.2017.10.046_bib0435) 2007; 39 Castangia (10.1016/j.ijpharm.2017.10.046_bib0065) 2013; 456 Raza (10.1016/j.ijpharm.2017.10.046_bib0490) 2013; 456 Sherry (10.1016/j.ijpharm.2017.10.046_bib0505) 2013; 23 López-Pinto (10.1016/j.ijpharm.2017.10.046_bib0330) 2005; 298 Lane (10.1016/j.ijpharm.2017.10.046_bib0345) 2013; 447 El Maghraby (10.1016/j.ijpharm.2017.10.046_bib0150) 2005; 305 Yokomizo (10.1016/j.ijpharm.2017.10.046_bib0580) 1996; 38 Alexander (10.1016/j.ijpharm.2017.10.046_bib0010) 2012; 164 Touitou (10.1016/j.ijpharm.2017.10.046_bib0550) 2000; 65 du Plessis (10.1016/j.ijpharm.2017.10.046_bib0615) 1994; 103 Foldvari (10.1016/j.ijpharm.2017.10.046_bib0180) 1990; 7 Trauer (10.1016/j.ijpharm.2017.10.046_bib0555) 2014; 86 Chathoth (10.1016/j.ijpharm.2017.10.046_bib0080) 2015; 6 El Maghraby (10.1016/j.ijpharm.2017.10.046_bib0155) 2008; 34 Paudel (10.1016/j.ijpharm.2017.10.046_bib0455) 2010; 1 Kumar (10.1016/j.ijpharm.2017.10.046_bib0320) 2012; 17 Jensen (10.1016/j.ijpharm.2017.10.046_bib0265) 2011; 79 Szura (10.1016/j.ijpharm.2017.10.046_bib0535) 2014; 71 Randhawa (10.1016/j.ijpharm.2017.10.046_bib0485) 2015; 50 Hood (10.1016/j.ijpharm.2017.10.046_bib0255) 2014; 9 Duangjit (10.1016/j.ijpharm.2017.10.046_bib0130) 2014; 9 Gillet (10.1016/j.ijpharm.2017.10.046_bib0210) 2011; 411 Regnier (10.1016/j.ijpharm.2017.10.046_bib0495) 1999; 184 Jain (10.1016/j.ijpharm.2017.10.046_bib0260) 2003; 29 Elsayed (10.1016/j.ijpharm.2017.10.046_bib0165) 2007; 332 Chen (10.1016/j.ijpharm.2017.10.046_bib0085) 2013; 39 Cronin (10.1016/j.ijpharm.2017.10.046_bib0100) 1999; 7 Gu (10.1016/j.ijpharm.2017.10.046_bib0225) 2009; 73 Lei Zhang (10.1016/j.ijpharm.2017.10.046_bib0360) 1997; 42 Yoshida (10.1016/j.ijpharm.2017.10.046_bib0590) 2010; 27 Geusens (10.1016/j.ijpharm.2017.10.046_bib0195) 2010; 62 Bolzinger (10.1016/j.ijpharm.2017.10.046_bib0045) 2012; 17 Mardhiah Adib (10.1016/j.ijpharm.2017.10.046_bib0405) 2016; 6 Zhai (10.1016/j.ijpharm.2017.10.046_bib0605) 2014; 193 Almandil (10.1016/j.ijpharm.2017.10.046_bib0015) 2016; 37 Bhalaria (10.1016/j.ijpharm.2017.10.046_bib0035) 2009; 47 Zellmer (10.1016/j.ijpharm.2017.10.046_bib0595) 1995; 1237 Lombardi Borgia (10.1016/j.ijpharm.2017.10.046_bib0375) 2005; 110 Manconi (10.1016/j.ijpharm.2017.10.046_bib0390) 2009; 342 Laouini (10.1016/j.ijpharm.2017.10.046_bib0350) 2013; 3 Melnik (10.1016/j.ijpharm.2017.10.046_bib0410) 1988; 119 El Maghraby (10.1016/j.ijpharm.2017.10.046_bib0145) 2004; 276 Williams (10.1016/j.ijpharm.2017.10.046_bib0570) 2003 Teeranachaideekul (10.1016/j.ijpharm.2017.10.046_bib0540) 2008; 128 Küchler (10.1016/j.ijpharm.2017.10.046_bib0270) 2009; 71 Riviere (10.1016/j.ijpharm.2017.10.046_bib0500) 2001; 50 Esposito (10.1016/j.ijpharm.2017.10.046_bib0170) 2004; 55 Gillet (10.1016/j.ijpharm.2017.10.046_bib0205) 2009; 380 Manca (10.1016/j.ijpharm.2017.10.046_bib0380) 2013; 455 Bhoyar (10.1016/j.ijpharm.2017.10.046_bib0040) 2012; 2 Lademann (10.1016/j.ijpharm.2017.10.046_bib0335) 2011; 77 Yatvin (10.1016/j.ijpharm.2017.10.046_bib0575) 1982; 9 Kato (10.1016/j.ijpharm.2017.10.046_bib0285) 1987; 39 Morrow (10.1016/j.ijpharm.2017.10.046_bib0415) 2007; 1 El Maghraby (10.1016/j.ijpharm.2017.10.046_bib0160) 2010; 397 Baron (10.1016/j.ijpharm.2017.10.046_bib0025) 2001; 1 Guo (10.1016/j.ijpharm.2017.10.046_bib0230) 2000; 194 El Maghraby (10.1016/j.ijpharm.2017.10.046_bib0140) 2000; 204 Loftsson (10.1016/j.ijpharm.2017.10.046_bib0370) 1997; 52 Betz (10.1016/j.ijpharm.2017.10.046_bib0030) 2001; 229 Guy (10.1016/j.ijpharm.2017.10.046_bib0235) 1987; 17 Pathan (10.1016/j.ijpharm.2017.10.046_bib0450) 2009; 8 Dubey (10.1016/j.ijpharm.2017.10.046_bib0135) 2007; 123 Mura (10.1016/j.ijpharm.2017.10.046_bib0420) 2009; 380 Porter (10.1016/j.ijpharm.2017.10.046_bib0470) 2013; 30 Baroli (10.1016/j.ijpharm.2017.10.046_bib0020) 2007; 127 Hadgraft (10.1016/j.ijpharm.2017.10.046_bib0240) 1999; 184 Kang (10.1016/j.ijpharm.2017.10.046_bib0280) 2007; 120 Cal (10.1016/j.ijpharm.2017.10.046_bib0060) 2008; 68 Nawaz (10.1016/j.ijpharm.2017.10.046_bib0425) 2016; 164 Fang (10.1016/j.ijpharm.2017.10.046_bib0175) 2009; 73 Keith (10.1016/j.ijpharm.2017.10.046_bib0295) 1982 van der Merwe (10.1016/j.ijpharm.2017.10.046_bib0620) 2006; 89 Souto (10.1016/j.ijpharm.2017.10.046_bib0525) 2004; 278 Subongkot (10.1016/j.ijpharm.2017.10.046_bib0530) 2013; 441 Potts (10.1016/j.ijpharm.2017.10.046_bib0475) 1995; 12 Verma (10.1016/j.ijpharm.2017.10.046_bib0560) 2004; 97 Kirjavainen (10.1016/j.ijpharm.2017.10.046_bib0300) 1996; 1304 Lee (10.1016/j.ijpharm.2017.10.046_bib0355) 2001; 75 Vogt (10.1016/j.ijpharm.2017.10.046_bib0565) 2006; 126 Dayan (10.1016/j.ijpharm.2017.10.046_bib0115) 2000; 21 Siafaka (10.1016/j.ijpharm.2017.10.046_bib0510) 2016; 17 Phatak (10.1016/j.ijpharm.2017.10.046_bib0460) 2013; 7 Zellmer (10.1016/j.ijpharm.2017.10.046_bib0600) 1995; 1237 Sinico (10.1016/j.ijpharm.2017.10.046_bib0520) 2005; 103 Paolino (10.1016/j.ijpharm.2017.10.046_bib0440) 2012; 81 Gillet (10.1016/j.ijpharm.2017.10.046_bib0215) 2011; 79 Lévy (10.1016/j.ijpharm.2017.10.046_bib0325) 2016; 113 Kawadkar (10.1016/j.ijpharm.2017.10.046_bib0290) 2013; 39 Yokomizo (10.1016/j.ijpharm.2017.10.046_bib0585) 1996; 42 Zhao (10.1016/j.ijpharm.2017.10.046_bib0610) 2013; 454 Lademann (10.1016/j.ijpharm.2017.10.046_bib0340) 2015; 08 |
References_xml | – volume: 27 start-page: 211 year: 2005 end-page: 221 ident: bib0095 article-title: Elastic vesicles as topical/transdermal drug delivery systems publication-title: Int. J. Cosmet. Sci. contributor: fullname: Maibach – volume: 366 start-page: 170 year: 2009 end-page: 184 ident: bib0445 article-title: Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products publication-title: Int. J. Pharm. contributor: fullname: Müller – volume: 4 start-page: 95 year: 1996 end-page: 101 ident: bib0185 article-title: Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles publication-title: J. Drug Target. contributor: fullname: Puglisi – volume: 39 start-page: 399 year: 1987 end-page: 400 ident: bib0285 article-title: Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride publication-title: J. Pharm. Pharmacol. contributor: fullname: Miyake – volume: 97 start-page: 55 year: 2004 end-page: 66 ident: bib0560 article-title: Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A publication-title: J. Control. Release contributor: fullname: Fahr – volume: 12 start-page: 1628 year: 1995 end-page: 1633 ident: bib0475 article-title: A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity publication-title: Pharm. Res. contributor: fullname: Guy – volume: 17 start-page: 1440 year: 2016 ident: bib0510 article-title: Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses publication-title: Int. J. Mol. Sci. contributor: fullname: Bikiaris – volume: 12 start-page: 297 year: 2005 end-page: 303 ident: bib0005 article-title: Testosterone ethosomes for enhanced transdermal delivery publication-title: Drug Deliv. contributor: fullname: Touitou – volume: 30 start-page: 2971 year: 2013 end-page: 2975 ident: bib0470 article-title: Recent advances in lipid-based formulation technology publication-title: Pharm. Res. contributor: fullname: Trevaskis – volume: 65 start-page: 403 year: 2000 end-page: 418 ident: bib0550 article-title: Ethosomes − novel vesicular carriers for enhanced delivery: characterization and skin penetration properties publication-title: J. Control. Release contributor: fullname: Eliaz – volume: 82 start-page: 49 year: 2012 end-page: 57 ident: bib0365 article-title: Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Liu – volume: 94 start-page: 365 year: 2004 end-page: 379 ident: bib0220 article-title: Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier publication-title: J. Control. Release contributor: fullname: Touitou – volume: 126 start-page: 1316 year: 2006 end-page: 1322 ident: bib0565 article-title: 40 nm, but not 750 or 1, 500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin publication-title: J. Invest. Dermatol. contributor: fullname: Blume-Peytavi – volume: 411 start-page: 223 year: 2011 end-page: 231 ident: bib0210 article-title: Liposome surface charge influence on skin penetration behaviour publication-title: Int. J. Pharm. contributor: fullname: Piel – volume: 229 start-page: 117 year: 2001 end-page: 129 ident: bib0030 article-title: Interaction of liposome formulations with human skin in vitro publication-title: Int. J. Pharm. contributor: fullname: Imanidis – volume: 164 start-page: 26 year: 2012 end-page: 40 ident: bib0010 article-title: Approaches for breaking the barriers of drug permeation through transdermal drug delivery publication-title: J. Controll. Release contributor: fullname: Tripathi – volume: 397 start-page: 164 year: 2010 end-page: 172 ident: bib0160 article-title: Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery publication-title: Int. J. Pharm. contributor: fullname: Mortada – volume: 127 start-page: 59 year: 2008 end-page: 69 ident: bib0125 article-title: Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies publication-title: J. Control. Release contributor: fullname: Fahr – volume: 78 start-page: 27 year: 2011 end-page: 35 ident: bib0395 article-title: Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Fadda – volume: 08 start-page: 1530004 year: 2015 ident: bib0340 article-title: Hair follicles as a target structure for nanoparticles publication-title: J. Innov. Opt. Health Sci. contributor: fullname: Patzelt – volume: 39 start-page: 20 year: 2013 end-page: 28 ident: bib0085 article-title: Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique publication-title: Drug Dev. Ind. Pharm. contributor: fullname: Yang – volume: 3 start-page: 4985 year: 2013 end-page: 4994 ident: bib0350 article-title: Preparation of liposomes: a novel application of microengineered membranes – investigation of the process parameters and application to the encapsulation of vitamin E publication-title: RSC Adv. contributor: fullname: Vladisavljević – volume: 34 start-page: 203 year: 2008 end-page: 222 ident: bib0155 article-title: Liposomes and skin: from drug delivery to model membranes publication-title: Eur. J. Pharm. Sci. contributor: fullname: Williams – volume: 132 start-page: 571 year: 1995 end-page: 579 ident: bib0315 article-title: Interaction of liposomes with human epidermis reconstructed in vitro publication-title: Br. J. Dermatol. contributor: fullname: Maierhofer – volume: 7 start-page: 230 year: 2012 end-page: 240 ident: bib0110 article-title: Elastic liposomes for delivery of neomycin sulphate in deep skin infection publication-title: Asian J. Pharm. Sci. contributor: fullname: Choudhary – volume: 68 start-page: 467 year: 2008 end-page: 478 ident: bib0060 article-title: Use of cyclodextrins in topical formulations: practical aspects publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Centkowska – volume: 42 start-page: 37 year: 1996 end-page: 46 ident: bib0585 article-title: The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers publication-title: J. Control. Release contributor: fullname: Sagitani – volume: 71 start-page: 243 year: 2009 end-page: 250 ident: bib0270 article-title: Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Kramer – volume: 62 start-page: 362 year: 2008 end-page: 379 ident: bib0480 article-title: Transfersomes: self-optimizing carriers for bioactives publication-title: PDA J. Pharm. Sci. Technol. PDA contributor: fullname: Jain – volume: 103 start-page: 277 year: 1994 end-page: 282 ident: bib0615 article-title: The influence of particle size of liposomes on the deposition of drug into skin publication-title: Int. J. Pharm. contributor: fullname: Müller – volume: 39 start-page: 349 year: 1990 end-page: 351 ident: bib0310 article-title: Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris publication-title: Eur. J. Clin. Pharmacol. contributor: fullname: Braun-Falco – volume: 81 start-page: 102 year: 2012 end-page: 112 ident: bib0440 article-title: Paclitaxel-loaded ethosomes publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Fresta – volume: 194 start-page: 201 year: 2000 end-page: 207 ident: bib0230 article-title: Lecithin vesicular carriers for transdermal delivery of cyclosporin A publication-title: Int. J. Pharm. contributor: fullname: Jiao – start-page: 121 year: 1992 end-page: 136 ident: bib0050 article-title: Changes in the structure of the human stratum corneum induced by liposomes publication-title: Liposome Dermatics, Griesbach Conference contributor: fullname: Junginger – volume: 123 start-page: 148 year: 2007 end-page: 154 ident: bib0135 article-title: Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes publication-title: J. Control. Release contributor: fullname: Jain – volume: 39 start-page: 569 year: 2013 end-page: 578 ident: bib0290 article-title: Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery publication-title: Drug Dev. Ind. Pharm. contributor: fullname: Chauhan – volume: 50 start-page: 175 year: 2001 end-page: 203 ident: bib0500 article-title: Potential and problems of developing transdermal patches for veterinary applications publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Papich – volume: 71 start-page: 224 year: 2013 end-page: 227 ident: bib0105 article-title: The combinational effect of PP electret and monoolein on transdermal delivery of cyclosporine A in vitro publication-title: J. Electrost. contributor: fullname: Jiang – volume: 456 start-page: 65 year: 2013 end-page: 72 ident: bib0490 article-title: Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity publication-title: Int. J. Pharm. contributor: fullname: Katare – volume: 455 start-page: 66 year: 2013 end-page: 74 ident: bib0380 article-title: Glycerosomes: a new tool for effective dermal and transdermal drug delivery publication-title: Int. J. Pharm. contributor: fullname: Fadda – volume: 89 start-page: 188 year: 2006 end-page: 204 ident: bib0620 article-title: A physiologically based pharmacokinetic model of organophosphate dermal absorption publication-title: Toxicol. Sci. contributor: fullname: Riviere – volume: 76 start-page: 56 year: 2010 end-page: 67 ident: bib0430 article-title: Preservation of nanostructured lipid carriers (NLC) publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Keck – volume: 380 start-page: 174 year: 2009 end-page: 180 ident: bib0205 article-title: Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome publication-title: Int. J. Pharm. contributor: fullname: Piel – volume: 311 start-page: 11 year: 2006 end-page: 19 ident: bib0385 article-title: Niosomes as carriers for tretinoin: III: A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin publication-title: Int. J. Pharm. contributor: fullname: Fadda – volume: 441 start-page: 151 year: 2013 end-page: 161 ident: bib0530 article-title: Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy publication-title: Int. J. Pharm. contributor: fullname: Ngawhirunpat – volume: 447 start-page: 12 year: 2013 end-page: 21 ident: bib0345 article-title: Skin penetration enhancers publication-title: Int. J. Pharm. contributor: fullname: Lane – volume: 58 start-page: 128 year: 2010 ident: bib0465 article-title: Elastic vesicles as drugs carriers through the skin publication-title: Farmacia contributor: fullname: Prisada – volume: 1304 start-page: 179 year: 1996 end-page: 189 ident: bib0300 article-title: Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure publication-title: Biochim. Biophys. Acta contributor: fullname: Mönkkönen – volume: 120 start-page: 211 year: 2007 end-page: 219 ident: bib0280 article-title: Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin publication-title: J. Control. Release contributor: fullname: Chan – volume: 1 start-page: 36 year: 2007 end-page: 59 ident: bib0415 article-title: Innovative strategies for enhancing topical and transdermal drug delivery publication-title: Open Drug Deliv. J. contributor: fullname: Donnelly – volume: 184 start-page: 147 year: 1999 end-page: 156 ident: bib0495 article-title: Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation publication-title: Int. J. Pharm. contributor: fullname: Préat – volume: 77 start-page: 465 year: 2011 end-page: 468 ident: bib0335 article-title: Penetration and storage of particles in human skin: perspectives and safety aspects publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Patzelt – volume: 443 start-page: 128 year: 2013 end-page: 136 ident: bib0055 article-title: Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs publication-title: Int. J. Pharm. contributor: fullname: Manconi – volume: 127 start-page: 1701 year: 2007 end-page: 1712 ident: bib0020 article-title: Penetration of metallic nanoparticles in human full-thickness skin publication-title: J. Invest. Dermatol. contributor: fullname: López-Quintela – volume: 128 start-page: 134 year: 2008 end-page: 141 ident: bib0540 article-title: Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC publication-title: J. Control. Release contributor: fullname: Junyaprasert – volume: 29 start-page: 1013 year: 2003 end-page: 1026 ident: bib0260 article-title: Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation publication-title: Drug Dev. Ind. Pharm. contributor: fullname: Jain – volume: 278 start-page: 71 year: 2004 end-page: 77 ident: bib0525 article-title: Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery publication-title: Int. J. Pharm. contributor: fullname: Müller – year: 2003 ident: bib0570 article-title: Transdermal and Topical Drug Delivery: from Theory to Clinical Practice contributor: fullname: Williams – volume: 110 start-page: 151 year: 2005 end-page: 163 ident: bib0375 article-title: Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy publication-title: J. Control. Release contributor: fullname: Schäfer-Korting – volume: 8 year: 2009 ident: bib0450 article-title: Chemical penetration enhancers for transdermal drug delivery systems publication-title: Trop. J. Pharm. Res. contributor: fullname: Setty – volume: 38 start-page: 267 year: 1996 end-page: 274 ident: bib0580 article-title: Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro publication-title: J. Controlled Release contributor: fullname: Sagitani – volume: 39 start-page: 659 year: 2007 end-page: 698 ident: bib0435 article-title: Drug-metabolizing enzymes in the skin of man, rat, and pig publication-title: Drug Metab. Rev. contributor: fullname: Landsiedel – volume: 1564 start-page: 21 year: 2002 end-page: 30 ident: bib0075 article-title: Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements publication-title: Biochim. Biophys. Acta contributor: fullname: Richardsen – volume: 27 start-page: 247 year: 2010 end-page: 259 ident: bib0120 article-title: Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery publication-title: Mol. Membr. Biol. contributor: fullname: Singh – volume: 17 start-page: 325 year: 1987 end-page: 343 ident: bib0235 article-title: Transdermal drug delivery and cutaneous metabolism publication-title: Xenobiotica contributor: fullname: Bucks – volume: 79 start-page: 68 year: 2011 end-page: 75 ident: bib0265 article-title: In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Nielsen – volume: 18 start-page: 170 year: 2005 end-page: 174 ident: bib0245 article-title: Sunscreen penetration of human skin and related keratinocyte toxicity after topical application publication-title: Skin Pharmacol. Physiol. contributor: fullname: Roberts – volume: 276 start-page: 143 year: 2004 end-page: 161 ident: bib0145 article-title: Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes publication-title: Int. J. Pharm. contributor: fullname: Barry – volume: 9 start-page: 149 year: 1982 end-page: 175 ident: bib0575 article-title: Clinical prospects for liposomes publication-title: Med. Phys. contributor: fullname: Lelkes – volume: 21 start-page: 938 year: 2012 end-page: 943 ident: bib0190 article-title: Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory model publication-title: Exp. Dermatol. contributor: fullname: Milner – volume: 390 start-page: 225 year: 2010 end-page: 233 ident: bib0275 article-title: SLN for topical application in skin diseases-characterization of drug-carrier and carrier-target interactions publication-title: Int. J. Pharm. contributor: fullname: Schäfer-Korting – volume: 1 start-page: 287 year: 2001 end-page: 291 ident: bib0025 article-title: Drug metabolism in the skin publication-title: Curr. Opin. Allergy Clin. Immunol. contributor: fullname: Merk – volume: 62 start-page: 788 year: 2010 ident: bib0195 article-title: Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in viable epidermis of ex-vivo human skin publication-title: J. Pharm. Pharmacol. contributor: fullname: Lambert – volume: 17 start-page: 1233 year: 2012 end-page: 1241 ident: bib0320 article-title: Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents publication-title: Drug Discov. Today contributor: fullname: Bali – volume: 332 start-page: 1 year: 2007 end-page: 16 ident: bib0165 article-title: Lipid vesicles for skin delivery of drugs: reviewing three decades of research publication-title: Int. J. Pharm. contributor: fullname: Khalafallah – start-page: 59 year: 1982 end-page: 69 ident: bib0295 article-title: Phospholipids as moisturizing agents publication-title: Princ. Cosmet. Dermatol. contributor: fullname: Snipes – volume: 86 start-page: 301 year: 2014 end-page: 306 ident: bib0555 article-title: Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Patzelt – volume: 79 start-page: 43 year: 2011 end-page: 53 ident: bib0215 article-title: Skin penetration behaviour of liposomes as a function of their composition publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Piel – volume: 73 start-page: 385 year: 2009 end-page: 390 ident: bib0225 article-title: Effects of penetration enhancers on Shuangwu traumatic formula: in vitro percutaneous absorption and in vivo pharmacodynamic evaluation of an herb medicine publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Ding – volume: 3 start-page: 497 year: 2011 end-page: 509 ident: bib0090 article-title: Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin publication-title: Pharmaceutics contributor: fullname: Fadda – volume: 412 start-page: 37 year: 2011 end-page: 46 ident: bib0400 article-title: Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin publication-title: Int. J. Pharm. contributor: fullname: Fadda – volume: 1104 start-page: 226 year: 1992 end-page: 232 ident: bib0070 article-title: Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force publication-title: Biochim. Biophys. Acta contributor: fullname: Blume – volume: 73 start-page: 391 year: 2009 end-page: 398 ident: bib0175 article-title: Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Tsai – volume: 119 start-page: 547 year: 1988 end-page: 549 ident: bib0410 article-title: Decreased stratum corneum ceramides in atopic individuals-a pathobiochemical factor in xerosis? publication-title: Br. J. Dermatol. contributor: fullname: Plewig – volume: 23 start-page: 268 year: 2013 end-page: 275 ident: bib0505 article-title: Essential oils encapsulated in liposomes: a review publication-title: J. Liposome Res. contributor: fullname: Greige-Gerges – volume: 454 start-page: 302 year: 2013 end-page: 309 ident: bib0610 article-title: Selection of high efficient transdermal lipid vesicle for curcumin skin delivery publication-title: Int. J. Pharm. contributor: fullname: Xu – volume: 9 start-page: e92978 year: 2014 ident: bib0255 article-title: Microfluidic-enabled liposomes elucidate size-dependent transdermal transport publication-title: PLoS One contributor: fullname: DeVoe – volume: 42 start-page: 283 year: 1997 end-page: 292 ident: bib0360 article-title: In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery publication-title: Bioelectrochem. Bioenerg. contributor: fullname: Lei Zhang – volume: 380 start-page: 72 year: 2009 end-page: 79 ident: bib0420 article-title: Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil publication-title: Int. J. Pharm. contributor: fullname: Fadda – volume: 2 start-page: 21 year: 2012 end-page: 39 ident: bib0040 article-title: Recent advances in novel drug delivery system through gels: review publication-title: J. Pharm. Allied Health Sci. contributor: fullname: Alexander – volume: 43 start-page: 282 year: 2015 end-page: 290 ident: bib0515 article-title: Vesicular system: versatile carrier for transdermal delivery of bioactives publication-title: Artif. Cells Nanomedicine Biotechnol. contributor: fullname: Singh – volume: 47 start-page: 368 year: 2009 end-page: 375 ident: bib0035 article-title: Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases publication-title: Indian J. Exp. Biol. contributor: fullname: Misra – volume: 456 start-page: 1 year: 2013 end-page: 9 ident: bib0065 article-title: Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles publication-title: Int. J. Pharm. contributor: fullname: Manconi – volume: 75 start-page: 155 year: 2001 end-page: 166 ident: bib0355 article-title: Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs publication-title: J. Control. Release contributor: fullname: Fang – volume: 204 start-page: 159 year: 2000 end-page: 169 ident: bib0140 article-title: Skin delivery of oestradiol from lipid vesicles: importance of liposome structure publication-title: Int. J. Pharm. contributor: fullname: Barry – volume: 6 start-page: 73 year: 2015 end-page: 82 ident: bib0080 article-title: Elevated fibroblast growth factor 23 concentration: prediction of mortality among chronic kidney disease patients publication-title: Cardiorenal Med. contributor: fullname: Al Ali – volume: 90 start-page: 243 year: 2003 end-page: 255 ident: bib0250 article-title: The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application publication-title: J. Control. Release contributor: fullname: Bouwstra – volume: 113 start-page: E8277 year: 2016 end-page: E8285 ident: bib0325 article-title: Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency publication-title: Proc. Natl. Acad. Sci. U. S. A. contributor: fullname: Puel – volume: 27 start-page: 416 year: 2010 end-page: 425 ident: bib0590 article-title: Liposomes incorporating essential oil of Brazilian cherry (Eugenia uniflora L.): characterization of aqueous dispersions and lyophilized formulations publication-title: J. Microencapsul. contributor: fullname: Pinho – volume: 6 start-page: 31 year: 2016 end-page: 36 ident: bib0405 article-title: The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: a histological study publication-title: Adv. Pharm. Bull. contributor: fullname: Hamishehkar – volume: 17 start-page: 156 year: 2012 end-page: 165 ident: bib0045 article-title: Penetration of drugs through skin, a complex rate-controlling membrane publication-title: Curr. Opin. Colloid Interface Sci. contributor: fullname: Chevalier – volume: 71 start-page: 145 year: 2014 end-page: 151 ident: bib0535 article-title: The impact of liposomes on transdermal permeation of naproxen-in vitro studies publication-title: Acta Pol. Pharm. contributor: fullname: Han – volume: 37 start-page: 1359 year: 2016 end-page: 1364 ident: bib0015 article-title: Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance publication-title: Saudi Med. J. contributor: fullname: Almandil – volume: 298 start-page: 1 year: 2005 end-page: 12 ident: bib0330 article-title: Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes publication-title: Int. J. Pharm. contributor: fullname: Rabasco – volume: 21 start-page: 1879 year: 2000 end-page: 1885 ident: bib0115 article-title: Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes publication-title: Biomaterials contributor: fullname: Touitou – volume: 342 start-page: 53 year: 2009 end-page: 58 ident: bib0390 article-title: Development and characterization of liposomes containing glycols as carriers for diclofenac publication-title: Colloids Surf. Physicochem. Eng. Asp. contributor: fullname: Molina – volume: 1237 start-page: 176 year: 1995 end-page: 182 ident: bib0600 article-title: Interaction of phosphatidylcholine liposomes with the human stratum corneum publication-title: Biochim. Biophys. Acta BBA-Biomembr. contributor: fullname: Lasch – volume: 71 start-page: 173 year: 2009 end-page: 180 ident: bib0305 article-title: Follicular transport route-research progress and future perspectives publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Vogt – volume: 7 start-page: 677 year: 2013 end-page: 685 ident: bib0460 article-title: Development and evaluation of Nanostructured Lipid Carrier (NLC) based topical delivery of an anti-inflammatory drug publication-title: J. Pharm. Res. contributor: fullname: Chaudhari – volume: 305 start-page: 90 year: 2005 end-page: 104 ident: bib0150 article-title: Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes publication-title: Int. J. Pharm. contributor: fullname: Finnin – volume: 2013 start-page: e616810 year: 2013 ident: bib0200 article-title: Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes publication-title: BioMed Res. Int. contributor: fullname: Arami – volume: 164 start-page: 160 year: 2016 end-page: 163 ident: bib0425 article-title: Synthesis, characterization, anti-bacterial, anti-fungal and nematicidal activities of 2-amino-3-cyanochromenes publication-title: J. Photochem. Photobiol. B contributor: fullname: Hisaindee – volume: 7 start-page: 325 year: 1999 end-page: 330 ident: bib0100 article-title: Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships publication-title: Eur. J. Pharm. Sci. contributor: fullname: Murray-Dickson – volume: 50 start-page: 119 year: 2015 end-page: 124 ident: bib0485 article-title: Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm publication-title: J. Environ. Sci. Health Part A contributor: fullname: Ali – volume: 103 start-page: 123 year: 2005 end-page: 136 ident: bib0520 article-title: Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction publication-title: J. Control. Release contributor: fullname: Fadda – volume: 55 start-page: 253 year: 2004 end-page: 264 ident: bib0170 article-title: Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study publication-title: J. Cosmet. Sci. contributor: fullname: Cortesi – volume: 1237 start-page: 176 year: 1995 end-page: 182 ident: bib0595 article-title: Interaction of phosphatidylcholine liposomes with the human stratum corneum publication-title: Biochim. Biophys. Acta contributor: fullname: Lasch – volume: 7 start-page: 479 year: 1990 end-page: 489 ident: bib0180 article-title: Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies publication-title: J. Microencapsul. contributor: fullname: Mezei – volume: 184 start-page: 1 year: 1999 end-page: 6 ident: bib0240 article-title: Passive enhancement strategies in topical and transdermal drug delivery publication-title: Int. J. Pharm. contributor: fullname: Hadgraft – volume: 9 start-page: 2005 year: 2014 end-page: 2017 ident: bib0130 article-title: Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes publication-title: Int. J. Nanomed. contributor: fullname: Ngawhirunpat – volume: 1 start-page: 109 year: 2010 end-page: 131 ident: bib0455 article-title: Challenges and opportunities in dermal/transdermal delivery publication-title: Ther. Deliv. contributor: fullname: Stinchcomb – volume: 52 start-page: 463 year: 1997 end-page: 465 ident: bib0370 article-title: Unsaturated glycerol monoethers as novel skin penetration enhancers publication-title: Pharmazie contributor: fullname: Olafsson – volume: 193 start-page: 90 year: 2014 end-page: 99 ident: bib0605 article-title: Advances in lipid-based colloid systems as drug carrier for topic delivery publication-title: J. Control. Release contributor: fullname: Zhai – volume: 456 start-page: 1 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0065 article-title: Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.08.034 contributor: fullname: Castangia – volume: 23 start-page: 268 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0505 article-title: Essential oils encapsulated in liposomes: a review publication-title: J. Liposome Res. doi: 10.3109/08982104.2013.819888 contributor: fullname: Sherry – volume: 73 start-page: 391 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0175 article-title: Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2009.07.011 contributor: fullname: Fang – volume: 39 start-page: 349 year: 1990 ident: 10.1016/j.ijpharm.2017.10.046_bib0310 article-title: Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/BF00315408 contributor: fullname: Korting – volume: 366 start-page: 170 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0445 article-title: Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.10.003 contributor: fullname: Pardeike – volume: 7 start-page: 479 year: 1990 ident: 10.1016/j.ijpharm.2017.10.046_bib0180 article-title: Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies publication-title: J. Microencapsul. doi: 10.3109/02652049009040470 contributor: fullname: Foldvari – volume: 456 start-page: 65 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0490 article-title: Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.08.019 contributor: fullname: Raza – volume: 120 start-page: 211 year: 2007 ident: 10.1016/j.ijpharm.2017.10.046_bib0280 article-title: Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin publication-title: J. Control. Release doi: 10.1016/j.jconrel.2007.05.006 contributor: fullname: Kang – volume: 455 start-page: 66 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0380 article-title: Glycerosomes: a new tool for effective dermal and transdermal drug delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.07.060 contributor: fullname: Manca – volume: 81 start-page: 102 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0440 article-title: Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2012.02.008 contributor: fullname: Paolino – volume: 132 start-page: 571 year: 1995 ident: 10.1016/j.ijpharm.2017.10.046_bib0315 article-title: Interaction of liposomes with human epidermis reconstructed in vitro publication-title: Br. J. Dermatol. doi: 10.1111/j.1365-2133.1995.tb08713.x contributor: fullname: Korting – volume: 390 start-page: 225 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0275 article-title: SLN for topical application in skin diseases-characterization of drug-carrier and carrier-target interactions publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2010.02.004 contributor: fullname: Küchler – volume: 17 start-page: 1440 year: 2016 ident: 10.1016/j.ijpharm.2017.10.046_bib0510 article-title: Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms17091440 contributor: fullname: Siafaka – volume: 204 start-page: 159 year: 2000 ident: 10.1016/j.ijpharm.2017.10.046_bib0140 article-title: Skin delivery of oestradiol from lipid vesicles: importance of liposome structure publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(00)00493-2 contributor: fullname: El Maghraby – volume: 1304 start-page: 179 year: 1996 ident: 10.1016/j.ijpharm.2017.10.046_bib0300 article-title: Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2760(96)00126-9 contributor: fullname: Kirjavainen – volume: 1 start-page: 109 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0455 article-title: Challenges and opportunities in dermal/transdermal delivery publication-title: Ther. Deliv. doi: 10.4155/tde.10.16 contributor: fullname: Paudel – volume: 75 start-page: 155 year: 2001 ident: 10.1016/j.ijpharm.2017.10.046_bib0355 article-title: Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs publication-title: J. Control. Release doi: 10.1016/S0168-3659(01)00391-1 contributor: fullname: Lee – volume: 9 start-page: 2005 year: 2014 ident: 10.1016/j.ijpharm.2017.10.046_bib0130 article-title: Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S60674 contributor: fullname: Duangjit – volume: 27 start-page: 416 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0590 article-title: Liposomes incorporating essential oil of Brazilian cherry (Eugenia uniflora L.): characterization of aqueous dispersions and lyophilized formulations publication-title: J. Microencapsul. doi: 10.3109/02652040903367327 contributor: fullname: Yoshida – volume: 89 start-page: 188 year: 2006 ident: 10.1016/j.ijpharm.2017.10.046_bib0620 article-title: A physiologically based pharmacokinetic model of organophosphate dermal absorption publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfj014 contributor: fullname: van der Merwe – year: 2003 ident: 10.1016/j.ijpharm.2017.10.046_bib0570 contributor: fullname: Williams – volume: 127 start-page: 1701 year: 2007 ident: 10.1016/j.ijpharm.2017.10.046_bib0020 article-title: Penetration of metallic nanoparticles in human full-thickness skin publication-title: J. Invest. Dermatol. doi: 10.1038/sj.jid.5700733 contributor: fullname: Baroli – volume: 6 start-page: 73 year: 2015 ident: 10.1016/j.ijpharm.2017.10.046_bib0080 article-title: Elevated fibroblast growth factor 23 concentration: prediction of mortality among chronic kidney disease patients publication-title: Cardiorenal Med. doi: 10.1159/000440984 contributor: fullname: Chathoth – volume: 86 start-page: 301 year: 2014 ident: 10.1016/j.ijpharm.2017.10.046_bib0555 article-title: Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2013.11.004 contributor: fullname: Trauer – volume: 47 start-page: 368 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0035 article-title: Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases publication-title: Indian J. Exp. Biol. contributor: fullname: Bhalaria – volume: 305 start-page: 90 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0150 article-title: Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.08.016 contributor: fullname: El Maghraby – volume: 18 start-page: 170 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0245 article-title: Sunscreen penetration of human skin and related keratinocyte toxicity after topical application publication-title: Skin Pharmacol. Physiol. doi: 10.1159/000085861 contributor: fullname: Hayden – volume: 39 start-page: 659 year: 2007 ident: 10.1016/j.ijpharm.2017.10.046_bib0435 article-title: Drug-metabolizing enzymes in the skin of man, rat, and pig publication-title: Drug Metab. Rev. doi: 10.1080/03602530701690366 contributor: fullname: Oesch – volume: 184 start-page: 1 year: 1999 ident: 10.1016/j.ijpharm.2017.10.046_bib0240 article-title: Passive enhancement strategies in topical and transdermal drug delivery publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(99)00095-2 contributor: fullname: Hadgraft – start-page: 121 year: 1992 ident: 10.1016/j.ijpharm.2017.10.046_bib0050 article-title: Changes in the structure of the human stratum corneum induced by liposomes contributor: fullname: Bouwstra – volume: 123 start-page: 148 year: 2007 ident: 10.1016/j.ijpharm.2017.10.046_bib0135 article-title: Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes publication-title: J. Control. Release doi: 10.1016/j.jconrel.2007.08.005 contributor: fullname: Dubey – volume: 71 start-page: 243 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0270 article-title: Nanoparticles for skin penetration enhancement-a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2008.08.019 contributor: fullname: Küchler – volume: 276 start-page: 143 year: 2004 ident: 10.1016/j.ijpharm.2017.10.046_bib0145 article-title: Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2004.02.024 contributor: fullname: El Maghraby – volume: 42 start-page: 283 year: 1997 ident: 10.1016/j.ijpharm.2017.10.046_bib0360 article-title: In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery publication-title: Bioelectrochem. Bioenerg. doi: 10.1016/S0302-4598(96)05128-8 contributor: fullname: Lei Zhang – volume: 164 start-page: 26 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0010 article-title: Approaches for breaking the barriers of drug permeation through transdermal drug delivery publication-title: J. Controll. Release doi: 10.1016/j.jconrel.2012.09.017 contributor: fullname: Alexander – volume: 9 start-page: e92978 year: 2014 ident: 10.1016/j.ijpharm.2017.10.046_bib0255 article-title: Microfluidic-enabled liposomes elucidate size-dependent transdermal transport publication-title: PLoS One doi: 10.1371/journal.pone.0092978 contributor: fullname: Hood – volume: 37 start-page: 1359 year: 2016 ident: 10.1016/j.ijpharm.2017.10.046_bib0015 article-title: Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance publication-title: Saudi Med. J. doi: 10.15537/smj.2016.12.17059 contributor: fullname: Almandil – volume: 43 start-page: 282 year: 2015 ident: 10.1016/j.ijpharm.2017.10.046_bib0515 article-title: Vesicular system: versatile carrier for transdermal delivery of bioactives publication-title: Artif. Cells Nanomedicine Biotechnol. doi: 10.3109/21691401.2014.883401 contributor: fullname: Singh – volume: 79 start-page: 43 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0215 article-title: Skin penetration behaviour of liposomes as a function of their composition publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2011.01.011 contributor: fullname: Gillet – volume: 342 start-page: 53 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0390 article-title: Development and characterization of liposomes containing glycols as carriers for diclofenac publication-title: Colloids Surf. Physicochem. Eng. Asp. doi: 10.1016/j.colsurfa.2009.04.006 contributor: fullname: Manconi – volume: 29 start-page: 1013 year: 2003 ident: 10.1016/j.ijpharm.2017.10.046_bib0260 article-title: Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation publication-title: Drug Dev. Ind. Pharm. doi: 10.1081/DDC-120025458 contributor: fullname: Jain – volume: 380 start-page: 72 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0420 article-title: Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2009.06.040 contributor: fullname: Mura – volume: 411 start-page: 223 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0210 article-title: Liposome surface charge influence on skin penetration behaviour publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2011.03.049 contributor: fullname: Gillet – volume: 38 start-page: 267 year: 1996 ident: 10.1016/j.ijpharm.2017.10.046_bib0580 article-title: Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro publication-title: J. Controlled Release doi: 10.1016/0168-3659(95)00127-1 contributor: fullname: Yokomizo – volume: 113 start-page: E8277 year: 2016 ident: 10.1016/j.ijpharm.2017.10.046_bib0325 article-title: Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1618300114 contributor: fullname: Lévy – volume: 9 start-page: 149 year: 1982 ident: 10.1016/j.ijpharm.2017.10.046_bib0575 article-title: Clinical prospects for liposomes publication-title: Med. Phys. doi: 10.1118/1.595079 contributor: fullname: Yatvin – volume: 1 start-page: 36 year: 2007 ident: 10.1016/j.ijpharm.2017.10.046_bib0415 article-title: Innovative strategies for enhancing topical and transdermal drug delivery publication-title: Open Drug Deliv. J. doi: 10.2174/1874126600701010036 contributor: fullname: Morrow – volume: 90 start-page: 243 year: 2003 ident: 10.1016/j.ijpharm.2017.10.046_bib0250 article-title: The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application publication-title: J. Control. Release doi: 10.1016/S0168-3659(03)00202-5 contributor: fullname: Honeywell-Nguyen – volume: 27 start-page: 211 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0095 article-title: Elastic vesicles as topical/transdermal drug delivery systems publication-title: Int. J. Cosmet. Sci. doi: 10.1111/j.1467-2494.2005.00264.x contributor: fullname: Choi – volume: 397 start-page: 164 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0160 article-title: Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2010.06.034 contributor: fullname: El Maghraby – volume: 193 start-page: 90 year: 2014 ident: 10.1016/j.ijpharm.2017.10.046_bib0605 article-title: Advances in lipid-based colloid systems as drug carrier for topic delivery publication-title: J. Control. Release doi: 10.1016/j.jconrel.2014.05.054 contributor: fullname: Zhai – start-page: 59 year: 1982 ident: 10.1016/j.ijpharm.2017.10.046_bib0295 article-title: Phospholipids as moisturizing agents contributor: fullname: Keith – volume: 443 start-page: 128 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0055 article-title: Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.12.041 contributor: fullname: Caddeo – volume: 39 start-page: 399 year: 1987 ident: 10.1016/j.ijpharm.2017.10.046_bib0285 article-title: Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1987.tb03407.x contributor: fullname: Kato – volume: 128 start-page: 134 year: 2008 ident: 10.1016/j.ijpharm.2017.10.046_bib0540 article-title: Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC publication-title: J. Control. Release doi: 10.1016/j.jconrel.2008.02.011 contributor: fullname: Teeranachaideekul – volume: 82 start-page: 49 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0365 article-title: Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2012.05.011 contributor: fullname: Li – volume: 103 start-page: 123 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0520 article-title: Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction publication-title: J. Control. Release doi: 10.1016/j.jconrel.2004.11.020 contributor: fullname: Sinico – volume: 380 start-page: 174 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0205 article-title: Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2009.06.027 contributor: fullname: Gillet – volume: 62 start-page: 788 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0195 article-title: Flexible nanosomes (SECosomes) enable efficient siRNA delivery in cultured primary skin cells and in viable epidermis of ex-vivo human skin publication-title: J. Pharm. Pharmacol. contributor: fullname: Geusens – volume: 441 start-page: 151 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0530 article-title: Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2012.12.003 contributor: fullname: Subongkot – volume: 71 start-page: 145 year: 2014 ident: 10.1016/j.ijpharm.2017.10.046_bib0535 article-title: The impact of liposomes on transdermal permeation of naproxen-in vitro studies publication-title: Acta Pol. Pharm. contributor: fullname: Szura – volume: 1237 start-page: 176 year: 1995 ident: 10.1016/j.ijpharm.2017.10.046_bib0595 article-title: Interaction of phosphatidylcholine liposomes with the human stratum corneum publication-title: Biochim. Biophys. Acta doi: 10.1016/0005-2736(95)00100-H contributor: fullname: Zellmer – volume: 12 start-page: 297 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0005 article-title: Testosterone ethosomes for enhanced transdermal delivery publication-title: Drug Deliv. doi: 10.1080/10717540500176910 contributor: fullname: Ainbinder – volume: 7 start-page: 230 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0110 article-title: Elastic liposomes for delivery of neomycin sulphate in deep skin infection publication-title: Asian J. Pharm. Sci. contributor: fullname: Darwhekar – volume: 8 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0450 article-title: Chemical penetration enhancers for transdermal drug delivery systems publication-title: Trop. J. Pharm. Res. doi: 10.4314/tjpr.v8i2.44527 contributor: fullname: Pathan – volume: 76 start-page: 56 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0430 article-title: Preservation of nanostructured lipid carriers (NLC) publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2010.05.001 contributor: fullname: Obeidat – volume: 1 start-page: 287 year: 2001 ident: 10.1016/j.ijpharm.2017.10.046_bib0025 article-title: Drug metabolism in the skin publication-title: Curr. Opin. Allergy Clin. Immunol. doi: 10.1097/01.all.0000011028.08297.b3 contributor: fullname: Baron – volume: 412 start-page: 37 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0400 article-title: Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2011.03.068 contributor: fullname: Manconi – volume: 71 start-page: 173 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0305 article-title: Follicular transport route-research progress and future perspectives publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2008.11.001 contributor: fullname: Knorr – volume: 71 start-page: 224 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0105 article-title: The combinational effect of PP electret and monoolein on transdermal delivery of cyclosporine A in vitro publication-title: J. Electrost. doi: 10.1016/j.elstat.2012.11.014 contributor: fullname: Cui – volume: 17 start-page: 325 year: 1987 ident: 10.1016/j.ijpharm.2017.10.046_bib0235 article-title: Transdermal drug delivery and cutaneous metabolism publication-title: Xenobiotica doi: 10.3109/00498258709043943 contributor: fullname: Guy – volume: 78 start-page: 27 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0395 article-title: Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2010.12.010 contributor: fullname: Manconi – volume: 184 start-page: 147 year: 1999 ident: 10.1016/j.ijpharm.2017.10.046_bib0495 article-title: Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(98)00085-4 contributor: fullname: Regnier – volume: 17 start-page: 156 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0045 article-title: Penetration of drugs through skin, a complex rate-controlling membrane publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/j.cocis.2012.02.001 contributor: fullname: Bolzinger – volume: 6 start-page: 31 year: 2016 ident: 10.1016/j.ijpharm.2017.10.046_bib0405 article-title: The effect of particle size on the deposition of solid lipid nanoparticles in different skin layers: a histological study publication-title: Adv. Pharm. Bull. doi: 10.15171/apb.2016.06 contributor: fullname: Mardhiah Adib – volume: 97 start-page: 55 year: 2004 ident: 10.1016/j.ijpharm.2017.10.046_bib0560 article-title: Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A publication-title: J. Control. Release doi: 10.1016/j.jconrel.2004.02.028 contributor: fullname: Verma – volume: 103 start-page: 277 year: 1994 ident: 10.1016/j.ijpharm.2017.10.046_bib0615 article-title: The influence of particle size of liposomes on the deposition of drug into skin publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(94)90178-3 contributor: fullname: du Plessis – volume: 50 start-page: 175 year: 2001 ident: 10.1016/j.ijpharm.2017.10.046_bib0500 article-title: Potential and problems of developing transdermal patches for veterinary applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(01)00157-0 contributor: fullname: Riviere – volume: 94 start-page: 365 year: 2004 ident: 10.1016/j.ijpharm.2017.10.046_bib0220 article-title: Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier publication-title: J. Control. Release doi: 10.1016/j.jconrel.2003.10.014 contributor: fullname: Godin – volume: 55 start-page: 253 year: 2004 ident: 10.1016/j.ijpharm.2017.10.046_bib0170 article-title: Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study publication-title: J. Cosmet. Sci. contributor: fullname: Esposito – volume: 39 start-page: 569 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0290 article-title: Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery publication-title: Drug Dev. Ind. Pharm. doi: 10.3109/03639045.2012.686509 contributor: fullname: Kawadkar – volume: 447 start-page: 12 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0345 article-title: Skin penetration enhancers publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.02.040 contributor: fullname: Lane – volume: 30 start-page: 2971 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0470 article-title: Recent advances in lipid-based formulation technology publication-title: Pharm. Res. doi: 10.1007/s11095-013-1229-7 contributor: fullname: Porter – volume: 127 start-page: 59 year: 2008 ident: 10.1016/j.ijpharm.2017.10.046_bib0125 article-title: Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies publication-title: J. Control. Release doi: 10.1016/j.jconrel.2007.12.013 contributor: fullname: Dragicevic-Curic – volume: 73 start-page: 385 year: 2009 ident: 10.1016/j.ijpharm.2017.10.046_bib0225 article-title: Effects of penetration enhancers on Shuangwu traumatic formula: in vitro percutaneous absorption and in vivo pharmacodynamic evaluation of an herb medicine publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2009.08.001 contributor: fullname: Gu – volume: 65 start-page: 403 year: 2000 ident: 10.1016/j.ijpharm.2017.10.046_bib0550 article-title: Ethosomes − novel vesicular carriers for enhanced delivery: characterization and skin penetration properties publication-title: J. Control. Release doi: 10.1016/S0168-3659(99)00222-9 contributor: fullname: Touitou – volume: 79 start-page: 68 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0265 article-title: In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2011.05.012 contributor: fullname: Jensen – volume: 42 start-page: 37 year: 1996 ident: 10.1016/j.ijpharm.2017.10.046_bib0585 article-title: The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers publication-title: J. Control. Release doi: 10.1016/0168-3659(96)01349-1 contributor: fullname: Yokomizo – volume: 119 start-page: 547 year: 1988 ident: 10.1016/j.ijpharm.2017.10.046_bib0410 article-title: Decreased stratum corneum ceramides in atopic individuals-a pathobiochemical factor in xerosis? publication-title: Br. J. Dermatol. doi: 10.1111/j.1365-2133.1988.tb03262.x contributor: fullname: Melnik – volume: 298 start-page: 1 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0330 article-title: Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.02.021 contributor: fullname: López-Pinto – volume: 77 start-page: 465 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0335 article-title: Penetration and storage of particles in human skin: perspectives and safety aspects publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2010.10.015 contributor: fullname: Lademann – volume: 50 start-page: 119 year: 2015 ident: 10.1016/j.ijpharm.2017.10.046_bib0485 article-title: Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm publication-title: J. Environ. Sci. Health Part A doi: 10.1080/10934529.2015.975042 contributor: fullname: Randhawa – ident: 10.1016/j.ijpharm.2017.10.046_bib0545 – volume: 1564 start-page: 21 year: 2002 ident: 10.1016/j.ijpharm.2017.10.046_bib0075 article-title: Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2736(02)00401-7 contributor: fullname: Cevc – volume: 454 start-page: 302 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0610 article-title: Selection of high efficient transdermal lipid vesicle for curcumin skin delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.06.052 contributor: fullname: Zhao – volume: 52 start-page: 463 year: 1997 ident: 10.1016/j.ijpharm.2017.10.046_bib0370 article-title: Unsaturated glycerol monoethers as novel skin penetration enhancers publication-title: Pharmazie contributor: fullname: Loftsson – volume: 27 start-page: 247 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0120 article-title: Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery publication-title: Mol. Membr. Biol. doi: 10.3109/09687688.2010.522203 contributor: fullname: Desai – volume: 3 start-page: 4985 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0350 article-title: Preparation of liposomes: a novel application of microengineered membranes – investigation of the process parameters and application to the encapsulation of vitamin E publication-title: RSC Adv. doi: 10.1039/c3ra23411h contributor: fullname: Laouini – volume: 34 start-page: 203 year: 2008 ident: 10.1016/j.ijpharm.2017.10.046_bib0155 article-title: Liposomes and skin: from drug delivery to model membranes publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2008.05.002 contributor: fullname: El Maghraby – volume: 126 start-page: 1316 year: 2006 ident: 10.1016/j.ijpharm.2017.10.046_bib0565 article-title: 40 nm, but not 750 or 1, 500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin publication-title: J. Invest. Dermatol. doi: 10.1038/sj.jid.5700226 contributor: fullname: Vogt – volume: 311 start-page: 11 year: 2006 ident: 10.1016/j.ijpharm.2017.10.046_bib0385 article-title: Niosomes as carriers for tretinoin: III: A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.11.045 contributor: fullname: Manconi – volume: 2013 start-page: e616810 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0200 article-title: Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes publication-title: BioMed Res. Int. doi: 10.1155/2013/616810 contributor: fullname: Ghanbarzadeh – volume: 2 start-page: 21 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0040 article-title: Recent advances in novel drug delivery system through gels: review publication-title: J. Pharm. Allied Health Sci. doi: 10.3923/jpahs.2012.21.39 contributor: fullname: Bhoyar – volume: 39 start-page: 20 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0085 article-title: Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique publication-title: Drug Dev. Ind. Pharm. doi: 10.3109/03639045.2011.650648 contributor: fullname: Chen – volume: 7 start-page: 325 year: 1999 ident: 10.1016/j.ijpharm.2017.10.046_bib0100 article-title: Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(98)00041-4 contributor: fullname: Cronin – volume: 1237 start-page: 176 year: 1995 ident: 10.1016/j.ijpharm.2017.10.046_bib0600 article-title: Interaction of phosphatidylcholine liposomes with the human stratum corneum publication-title: Biochim. Biophys. Acta BBA-Biomembr. doi: 10.1016/0005-2736(95)00100-H contributor: fullname: Zellmer – volume: 4 start-page: 95 year: 1996 ident: 10.1016/j.ijpharm.2017.10.046_bib0185 article-title: Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles publication-title: J. Drug Target. doi: 10.3109/10611869609046267 contributor: fullname: Fresta – volume: 194 start-page: 201 year: 2000 ident: 10.1016/j.ijpharm.2017.10.046_bib0230 article-title: Lecithin vesicular carriers for transdermal delivery of cyclosporin A publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(99)00361-0 contributor: fullname: Guo – volume: 17 start-page: 1233 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0320 article-title: Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2012.06.013 contributor: fullname: Kumar – volume: 62 start-page: 362 year: 2008 ident: 10.1016/j.ijpharm.2017.10.046_bib0480 article-title: Transfersomes: self-optimizing carriers for bioactives publication-title: PDA J. Pharm. Sci. Technol. PDA contributor: fullname: Rai – volume: 332 start-page: 1 year: 2007 ident: 10.1016/j.ijpharm.2017.10.046_bib0165 article-title: Lipid vesicles for skin delivery of drugs: reviewing three decades of research publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2006.12.005 contributor: fullname: Elsayed – volume: 164 start-page: 160 year: 2016 ident: 10.1016/j.ijpharm.2017.10.046_bib0425 article-title: Synthesis, characterization, anti-bacterial, anti-fungal and nematicidal activities of 2-amino-3-cyanochromenes publication-title: J. Photochem. Photobiol. B doi: 10.1016/j.jphotobiol.2016.09.032 contributor: fullname: Nawaz – volume: 1104 start-page: 226 year: 1992 ident: 10.1016/j.ijpharm.2017.10.046_bib0070 article-title: Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force publication-title: Biochim. Biophys. Acta doi: 10.1016/0005-2736(92)90154-E contributor: fullname: Cevc – volume: 110 start-page: 151 year: 2005 ident: 10.1016/j.ijpharm.2017.10.046_bib0375 article-title: Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy publication-title: J. Control. Release doi: 10.1016/j.jconrel.2005.09.045 contributor: fullname: Lombardi Borgia – volume: 21 start-page: 1879 year: 2000 ident: 10.1016/j.ijpharm.2017.10.046_bib0115 article-title: Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes publication-title: Biomaterials doi: 10.1016/S0142-9612(00)00063-6 contributor: fullname: Dayan – volume: 278 start-page: 71 year: 2004 ident: 10.1016/j.ijpharm.2017.10.046_bib0525 article-title: Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2004.02.032 contributor: fullname: Souto – volume: 21 start-page: 938 year: 2012 ident: 10.1016/j.ijpharm.2017.10.046_bib0190 article-title: Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory model publication-title: Exp. Dermatol. doi: 10.1111/exd.12051 contributor: fullname: Frušić-Zlotkin – volume: 7 start-page: 677 year: 2013 ident: 10.1016/j.ijpharm.2017.10.046_bib0460 article-title: Development and evaluation of Nanostructured Lipid Carrier (NLC) based topical delivery of an anti-inflammatory drug publication-title: J. Pharm. Res. contributor: fullname: Phatak – volume: 229 start-page: 117 year: 2001 ident: 10.1016/j.ijpharm.2017.10.046_bib0030 article-title: Interaction of liposome formulations with human skin in vitro publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(01)00824-9 contributor: fullname: Betz – volume: 58 start-page: 128 year: 2010 ident: 10.1016/j.ijpharm.2017.10.046_bib0465 article-title: Elastic vesicles as drugs carriers through the skin publication-title: Farmacia contributor: fullname: Pirvu – volume: 68 start-page: 467 year: 2008 ident: 10.1016/j.ijpharm.2017.10.046_bib0060 article-title: Use of cyclodextrins in topical formulations: practical aspects publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2007.08.002 contributor: fullname: Cal – volume: 08 start-page: 1530004 year: 2015 ident: 10.1016/j.ijpharm.2017.10.046_bib0340 article-title: Hair follicles as a target structure for nanoparticles publication-title: J. Innov. Opt. Health Sci. doi: 10.1142/S1793545815300049 contributor: fullname: Lademann – volume: 3 start-page: 497 year: 2011 ident: 10.1016/j.ijpharm.2017.10.046_bib0090 article-title: Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin publication-title: Pharmaceutics doi: 10.3390/pharmaceutics3030497 contributor: fullname: Chessa – volume: 12 start-page: 1628 year: 1995 ident: 10.1016/j.ijpharm.2017.10.046_bib0475 article-title: A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity publication-title: Pharm. Res. doi: 10.1023/A:1016236932339 contributor: fullname: Potts |
SSID | ssj0006213 |
Score | 2.6634336 |
SecondaryResourceType | review_article |
Snippet | [Display omitted]
During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid... During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid nanocarriers enable... |
SourceID | hal proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1 |
SubjectTerms | Delivery Dermal Disease Ethosomes Life Sciences Liposomes Nanocarrier Nanoparticles Permeation Pharmaceutical sciences Transdermal Transfersomes |
Title | Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications |
URI | https://dx.doi.org/10.1016/j.ijpharm.2017.10.046 https://www.ncbi.nlm.nih.gov/pubmed/29111097 https://search.proquest.com/docview/1961644358 https://hal.science/hal-02093089 |
Volume | 535 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-a9GUvo_tOtxVtjD7FiW3JH9pbKC3ZByWwFvomHEnenC1OsJNCXva37y6ykxZWBgODseBkoZPvfrLufgfwITZ5Fuoo8YyNfE_kWeIRbZ0XUu1oE1qZ6C3b52U8vhafb6KbAzhrc2EorLKx_c6mb6110zJsZnO4LIrhN59vC8tzunAnkXbgEN2REF04HH36Mr7cGeQ4bKok44aJBPaJPMPZoJgtiSOagrySAcV5ERT-u4vq_KBYyYeA6NYhXRzB4wZJspEb7BM4sOVTOJ04KupNn13tM6vqPjtlkz1J9eYZ3FLRasPKrERnVlHZupplNat_FiUz1fo7M_YXhWxsmON6rj-yCf23r4iAtc_mljKGi3pes0XupIh4onJpEthVadjcnQGxu2fkz-H64vzqbOw1NRg8jdBl5cVJHnHBdZpHudACdyNmqqUWmSRivyCVWZYKiTgs9iWPdWxCw3GOTYa30OQJfwHdclHaV8AQKqIGZBJYFIm4RWCGwvk00r5BmKl7MGinXS0d1YZqY9BmqtGTIj1RM-qpB2mrHHVvzSh0B_8SfY_K3L2GOLbHo6-K2hA_S-6n8jbowbtW1wo_OjpJyUq7WNcKzRZuMxFppj146RbBrq-Q3Icvk-P_H91reIRPFGToBdEb6K6qtX2L2Gc1PYHO4Hdw0qzwP_7_A84 |
link.rule.ids | 230,315,786,790,891,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_a9GF7Kfte9qmN0ac4sS3bsvYWyoq7ZiGwFPomHEnenDVOsJNC_vvdxXaywcZgYDDInCx08t1P1t3vAD5EJkt9HQrH2NB1giwVDtHWOT7Vjja-lULv2D7HUXIdfL4Jb47gvM2FobDKxvbXNn1nrZuWQTObg1WeD766fFdYntOFO4n4GE6CUHhBB06Gl1fJeG-QI7-pkowbJhI4JPIM5v18viKOaAryEn2K8yIo_GcXdfydYiX_BkR3DuniAZw2SJIN68E-hCNbPIKzSU1Fve2x6SGzquqxMzY5kFRvH8MdFa02rEgLdGYlla2rWFqx6kdeMFNuvjFjbylkY8tqrufqI5vQf_uSCFh7bGEpYzivFhVbZrUUEU-UdZoEdlUYtqjPgNivZ-RP4Pri0_Q8cZoaDI5G6LJ2IpGFPOA6zsIs0AHuRsxMSx2kkoj9vFimaRxIxGGRK3mkI-MbjnNsUrz5JhP8KXSKZWGfA0OoiBqQwrMoEnKLwAyFs1moXYMwU3eh3067WtVUG6qNQZurRk-K9ETNqKcuxK1y1G9rRqE7-Jfoe1Tm_jXEsZ0MR4raED9L7sbyzuvCu1bXCj86OklJC7vcVArNFm4zEWnGXXhWL4J9Xz65D1eKF_8_urdwL5l-GanR5fjqJdzHJxRw6HjhK-isy419jThoPXvTrPOfQFcFwA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lipid+nanocarriers+as+skin+drug+delivery+systems%3A+Properties%2C+mechanisms+of+skin+interactions+and+medical+applications&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Sala%2C+M.&rft.au=Diab%2C+R.&rft.au=Elaissari%2C+A.&rft.au=Fessi%2C+H.&rft.date=2018-01-15&rft.issn=0378-5173&rft.volume=535&rft.issue=1-2&rft.spage=1&rft.epage=17&rft_id=info:doi/10.1016%2Fj.ijpharm.2017.10.046&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijpharm_2017_10_046 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon |